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ABSTRACT 
 
The pet population is growing at a fast pace and 91.7% of 2,668 American pet owners 
consider their dog as part of their family. Thus, the importance of longevity and health of 
companion animals has been a constant concern for pet parents, and diet plays an important role 
in that. The use of prebiotics and dietary fibers have gained renewed interest in the pet food 
industry as a strategy to modulate gut health. Dietary fibers are heterogeneous compounds that 
exert different physiological responses and health benefits depending on their physical and 
chemical characteristics. Different types of prebiotics can be incorporated in diets of dogs and their 
efficacy is related to their structure, form of supplementation, and dosage. Both prebiotics and 
dietary fibers are non-digestible ingredients that may confer benefits to the host by selectively 
stimulating beneficial intestinal bacteria and affecting rate of fermentation and concentrations of 
fermentative end-products. Therefore, the aim of this experiment was to evaluate the effects of a 
prebiotic and dietary fiber blend with or without a gut health promoter on outcomes pertaining to 
gastrointestinal health and nutrient digestibility by adult dogs. Four diets containing either 5% of 
cellulose (CT), 5% fiber and prebiotic blend (FP), 0.02% of a gut health promoter additive (GP), 
or 5% fiber and prebiotic blend plus 0.02% of gut health promoter (FG) were formulated to meet 
or exceed the AAFCO (2017) nutritional requirements of adult dogs. Eight adult female beagles 
(mean age 4.2 ± 1.1 yr; mean BW = 10.8 ± 1.4 kg; mean BCS = 5.8 ± 0.6) were randomly assigned 
to one of the four dietary treatments using a replicated 4 x 4 Latin square design. Each experimental 
period consisted of 14 days (10 days of diet adaptation + 4 days of total and fresh fecal and total 
urine collection). Food was offered twice daily and fed to maintain body weight. Food intake and 
total fecal and urine output were measured and sampled for macronutrient analyses and 
digestibility calculations. Blood samples were collected at the end of each period for serum 
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chemistry analysis and complete blood count. A fresh fecal sample from each dog was collected 
within 15 minutes of defecation and analyzed for dry matter (DM), phenols and indoles, short-
chain fatty acids (SCFA), branched-chain fatty acids (BCFA), and microbiota. The data were 
analyzed using The MIXED procedure using SAS, version 9.4. Total DNA from fresh fecal 
samples was extracted using Mo-Bio PowerSoil kits, sequencing was performed on a MiSeq and 
data were analyzed using QIIME 1.9.1. All animals remained healthy throughout the study, with 
serum metabolites being within reference ranges for adult dogs. All diets were well accepted by 
the dogs, resulting in similar (P > 0.05) daily food intakes among treatments. Likewise, fecal 
output and scores did not differ (P > 0.05) among dietary treatments, with the latter being within 
an ideal range (2.5-2.9). All diets were highly digested by dogs, and had a similar (P > 0.05) 
apparent total tract digestibility (ATTD) of dry matter (DM) (81.6-84.4%), organic matter (OM) 
(86.4-87.3%), and crude protein (CP) (86.6-87.3%). However, ATTD of total dietary fiber (TDF) 
was greater for dogs fed the FG  diet (P < 0.05) in contrast with dogs fed the GP and CT diets, 
while dogs fed the FP diets had intermediate TDF digestibilities but not different from CT, FG or 
GP. Fecal acetate and propionate concentrations were greater (P < 0.05) for dogs fed FP and FG 
diets. The concentration of fecal butyrate did not differ among treatments (P > 0.05). Fecal 
concentrations of isobutyrate and isovalerate were greater for dogs fed CT (P < 0.05) compared to 
dogs fed the other three treatments.  No shifts in fecal microbial richness and diversity were 
observed when dogs consumed diets containing the fiber and prebiotic blend and (or) the gut health 
promoter additive. Overall, the data suggest that dietary supplementation of fiber and prebiotic 
blend were well tolerated by dogs, did not cause detrimental effects on fecal quality or nutrient 
digestibility, and resulted in beneficial shifts in fecal fermentative end-products that may support 
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gut health. They also suggest a potential synergistic effect between fiber and prebiotic blend wth 
gut heath promoter that warrants further investigation.  
Key words: dietary fiber, dogs, gut health, microbiota, and nutrient digestibility. 
  
v 
 
ACKNOWLEDGEMENTS 
 First, I thank my advisor, Dr. Maria Regina Cattai de Godoy, for giving me the opportunity to 
come to the University of Illinois and beging this journey. I cannot thank her enough for the trust in 
my work and for all the patience with my learning and adapting processes. Maria’s emotional and 
professional support, friendship, and intelligence as a mentor inspired me so much, and helped me 
knock down many obstacles in order to get closer to my goal. Dear Maria, you are everything one 
could look for in a good mentor, and I will always be thankful to you.  
Second, I would like to thank Dr. Kelly Swanson and Dr. George Fahey for being an absolute 
inspiration as professors, scientists, and amazing people, and for serving on my committee. I thank 
them for all the knowledge they have shared. Maria, Kelly and Fahey: I hope to put into practice 
everything you taught me, honor the career, and make you proud of every achievement. I will keep in 
my memory everything that I have learned from you and in my heart all the gratitude and respect for 
you. As Isaac Newton once said: “If I have seen a little further it is by standing on the shoulders of 
giants”.  
I also thank Dr. Márcio Antonio Brunetto for being my first inspiration to work hard, do 
research, and seek out more answers in the companion animal nutrition area. I am very thankful for his 
mentorship, for pushing me and believing in me. I also thank many other professors who taught me so 
much during my entire education, since elementary school to graduate school. You all have inspired 
me and have made me a passionate learner. From the University of Illinois, I would like to thank some 
professors that were not from the companion animal field; they taught me a lot and inspired me during 
Graduate School: Dr. Hans H. Stein and Dr. Lori T. Raetzman. 
I would like to thank all members of the Godoy-Swanson labs for the team work. It is very 
satisfying to see two big labs working with a shared goal of finding answers that can help our four-
pawed best friends. I especially thank my coworkers and friends that Graduate School gave me: Patricia 
Massae Oba, Lauren Reilly, Zac Traughber, Katelyn Detweiler, Patrick von Schaumburg, and 
vi 
 
Meredith Carroll – thank you for making lab work so fun and for all of your friendship. I also thank 
the visiting scholars and undergraduate students for helping with the care of the animals, and well as 
Drs. Fei He and Heather Mangian for their analytical training and support in the lab. I also thank the 
dogs and cats that we have in our facilities that have allowed and helped us find more answers in order 
to help other dogs and cats in the future.  
I am forever grateful for all of my friends that were always present throughout this journey, 
some being here and some in Brazil. Thank you so much for your forever friendship, love, and 
affection. I especially thank my friends Ana Carla, Ana Cláudia, and Camila who even from miles and 
miles away were always present and gave me all the encouragement, friendship, and affection that 
made all the difference. I also thank with all my heart the friends that I made here and that I will take 
forever in my heart: Lídia, Murilo, Fernanda, Hans, Matteo, Rachel, Tassia and Pedro Miguel – thank 
you so much for being my family here and for all the care, support, love, laugh, and lots of great 
conversation and special memories that you helped me build. I would not have survived without you!  
I thank my beloved boyfriend, Rogério, for the endless support and friendship in this journey. 
I cannot thank him enough for always being by my side, for all the great conversations and laughter, 
and for teaching me how to live life in a more positive and relaxed way. I also thank him for the support 
during my endless work hours and for helping me in every single decision that I have made.  
Finally, I want to thank my family, especially my parents Sandra and Fernando, for being my 
greatest support system. Thank you so much for helping me go through the ups and downs of graduate 
school, for the endless support during my entire life, and during this journey. Thank you for believing 
in me and pushing me every time that things got hard. I also thank my family of dogs and cats – Malu, 
Mike, and Simba, who bring endless love, support, and companionship to every single day of my life.  
 
  
vii 
 
 
 
 
 
 
 
 
To My Parents 
Thank you for never leting me feel alone in this journey, even with me being on the other side of 
the world. I could not have accomplished this without you.   
 
 
 
 
 
 
 
  
viii 
 
TABLE OF CONTENTS 
CHAPTER 1: INTRODUCTION ...........................................................................................1 
LITERATURE CITED .........................................................................................................3 
CHAPTER 2: LITERATURE REVIEW ...............................................................................4 
DIETARY FIBER: DEFINITION AND CLASSIFICATION .............................................4 
DIETARY FIBER IN CANINE NUTRITION .....................................................................7 
PREBIOTICS: DEFINITION AND CLASSIFICATION ..................................................12 
PREBIOTICS IN CANINE NUTRITON ...........................................................................14 
GUT PROMOTERS IN CANINE NUTRITION ...............................................................20 
THE IMPORTANCE OF THE GUT MICROBIOTA........................................................22 
MODULATION OF THE CANINE GUT MICROBIOTA BY PREBIOTICS AND DIETARY 
FIBERS ...............................................................................................................................24 
THESIS OBJECTIVES .......................................................................................................29 
LITERATURE CITED .......................................................................................................30 
CHAPTER 3: DIETARY SUPPLEMENTATION OF A FIBER-PREBIOTIC-GUT HEALTH 
PROMOTER BLEND IN EXTRUDED DIETS FED TO DOGS .....................................41 
ABSTRACT ........................................................................................................................41 
INTRODUCTION ..............................................................................................................42 
MATERIALS AND METHODS ........................................................................................44 
RESULTS ...........................................................................................................................48 
DISCUSSION .....................................................................................................................52 
IMPLICATIONS ................................................................................................................65 
TABLES..............................................................................................................................66 
FIGURES ............................................................................................................................72
LITERATURE CITED .......................................................................................................77 
 1 
CHAPTER 1: INTRODUCTION 
The pet population is growing at a fast pace. In 2012, the American Veterinary Medical 
Association (AVMA) published the U.S. Pet Ownership Statistics and reported a total number of 
dogs and cats of 70 and 74 million, respectively. They also stated that about 36.5% and 30.4% of 
U.S. households owned a dog and cat, respectively. Recently, the National Pet Owners Survey 
Statistics reported the total number of pets owned in the U.S. are 89.7 millions dogs and 94.2 
millions cats, accounting for 68% of U.S. households owning a pet (APPA, 2018). In addition, a 
survey that is being conducted by the Companion Animal and Comparative Nutrition Laboratory 
in the Animal Sciences Department at the University of Illinois at Urbana-Champaign, 91.8% of 
2,671 American pet owners consider their dog as part of their family, 85% consider very important 
that their dog eats healthy, and 91.5% of dog owners would be willing to spend more to provide a 
healthier food for their dog. Thus, the importance of longevity and health of companion animals 
has been a constant concern by pet parents, and it can be influenced by several factors, such as diet 
(Fahey et al., 2004).  
In this manner, pet parents have been increasingly more aware of the importance of 
nutrition for their pet’s health, performance, longevity, and disease prevention (Thatcher et al., 
2010), and the pet food industry is following these expectations. According to statistics gathered 
by APPA (2018) from various market research sources, total U.S. pet industry expenditures were 
$17 billions in 1994, and this number is now four fold higher. Thus, in 2017, $69.51 billion was 
spent on pets in the U.S., with $29 billion representing pet food, accounting for 42% of the total 
U.S. pet industry market share. In this scenario of humanization of pets and increased food options 
for pets, owners often choose to feed their dogs with diets that fit their own nutritional philosophies 
and in theory contain ingredients and nutrients that will promote the longevity and quality of life 
of their dogs (Case, 2014). Dietary fibers and prebiotics have been the focus of most nutritional 
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strategies studied to modulate the canine gastrointestinal microbiota (Hooda et al., 2012). 
Depending on dietary fiber`s physical and chemical characteristics, their inclusion in diets of 
companion animals can have many benefits. The most common fiber sources used for companion 
animals are beet pulp and cellulose (de Godoy et al., 2013). In addition, prebiotics are utilized in 
companion animal diet so the host microorganisms can utilize it and confer a health benefit for the 
pet (Gibson et al., 2017).     
However, no studies have evaluated the effects of a blend of dietary fibers, prebiotic and a 
gut health promoter in health adult dogs. Hence, the objective of this research was to determine 
the effects of dietary supplementation of fibers and prebiotic blend alone or in combination with a 
gut health promoter additive on the gastrointestinal health of adult dogs through the determination 
of apparent total tract macronutrient digestibility, fecal characteristics and fermentative end-
products, and fecal microbiota.   
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CHAPTER 2: LITERATURE REVIEW 
 
DIETARY FIBER: DEFINITION AND CLASSIFICATION 
Given the increasing humanization of pets and the fact that trends occurring in the human 
food industry are translated into pet foods some time later, dietary fibers have been extensevily 
used by the pet food industry. On May 27, 2016, the U.S. Food and Drug Administration (FDA) 
announced the Nutrition and Supplement Facts label final rule, which included a definition of 
dietary fiber as “non-digestible soluble and insoluble carbohydrates (with 3 or more monomeric 
units), and lignin that are intrinsic and intact in plants; isolated or synthetic non-digestible 
carbohydrates (with 3 or more monomeric units) determined by FDA to have physiological effects 
that are beneficial to human health”. According to FDA, a dietary fiber has to be demonstrated 
beneficial to humans for at least one of the following criteria: lowering blood glucose and 
cholesterol levels, lowering blood pressure, increasing frequency of bowel movements (improved 
laxation), increasing mineral absorption in the intestinal tract, and (or) reducing energy intake (for 
example, due to the fiber-promoting a feeling of fullness). In addition, according to FDA, “colonic 
fermentation and short-chain fatty acid (SCFA) production and modulation of the colonic 
microbiota are not considered beneficial effects, since both of these processes are associated with 
a physiological endpoint, but are not physiological endpoints themselves”. Thus, FDA approved 
only naturally occurring fibers that are "intrinsic and intact" in plants, and certain isolated or 
synthetic non-digestible soluble and insoluble carbohydrates that can be declared on the Nutrition 
and Supplement Facts labels. So far, FDA approved as dietary fibers the following non-digestible 
carbohydrates: beta-glucan soluble fiber, psyllium husk, cellulose, guar gum, pectin, locust bean 
gum, hydroxypropylmethylcellulose, mixed plant cell wall fibers (a broad category that includes 
fibers like sugar cane fiber and apple fiber, among many others), arabinoxylan, alginate, inulin and 
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inulin-type fructans, high amylose starch (resistant starch 2), galactooligosaccharide, 
polydextrose, and resistant maltodextrin/dextrin.  
Dietary fibers can be classified in different ways, including their structure (i.e., linear or 
nonlinear molecule), solubility (i.e., soluble or insoluble molecule), fermentability (i.e., 
nonfermentable fibers, partially fermentable fibers or completely fermentable fibers) and viscosity 
(i.e., viscous or non-viscous fibers; Dai and Chau, 2016; Schneeman, 1994). Chemically, dietary 
fibers are composed of insoluble fibers, such as cellulose, hemicelluloses, and lignin, and soluble 
fibers such as pectins, beta-glucans, gums, mucilages, and oligosaccharides (Fahey et al., 2018). 
There are different methods for measuring fiber concentrations, and which rely on chemical 
solubility methods for different portions of the fiber to isolate and measure relevant fiber fractions 
(Fahey et al., 2018). Currently, there are different analyses used to quantify dietary fiber in food 
and feeds, such as: crude fiber (CF), neutral detergent fiber (NDF), acid detergent fiber (ADF), 
amylase-treated NDF (aNDF), total dietary fiber (TDF), insoluble dietary fiber (IDF), soluble 
dietary fiber (SDF), and nonstarch polysaccharides (NSP; Fahey et al., 2018). At present, the legal 
measure of fiber in plant tissues, manufactured livestock feeds, and pet foods in the United States 
is CF. However, some of the lignin, phenolic complexes, and hemicelluloses are not quantified in 
this method, resulting in an amount of fiber that in fact underestimates the true fiber content by 
30–50% (Fahey et al., 2018). Another method that has been used to quantify dietary fiber in foods, 
complete feeds, feed ingredients and byproduct feeds is the TDF method, which is the sum of 
soluble and insoluble dietary fiber fractions. TDF methods allow a detailed analysis of sugars, 
starches, nondigestible oligosaccharides, noncellulosic polysaccharides, cellulose, and lignin and 
often are used for the analysis of complex food matrixes that include isolated/extracted fibers (e.g., 
inulin) and/or synthetic fibers (e.g., resistant maltodextrins) in addition to natural ingredient fiber 
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sources (Fahey et al., 2018). Thus, for practical purposes, most of the components of dietary fiber 
present in a material are measured.    
Studies in human nutrition have shown that the daily recommended intake levels of dietary 
fiber reduce the risk for developing diseases such as coronary heart disease (Wolk et al., 1999), 
hypertension (Whelton et al., 2005), diabetes (Montonen et al., 2003), obesity (Lairon et al., 2005), 
and some gastrointestinal disorders (Petruziello et al., 2006). In human nutrition, the current 
recommended levels for dietary fiber intake depend on age, gender, and energy intake; however, 
the general recommendation for an adequate daily fiber intake is 14g/1000 kcal, which for an 
average adult means a daily intake of 25 g (female) or 38 g (male; Dietary Guideline, 2015-2020). 
Following the same trend, dietary fibers have gained renewed interest in the pet food industry (de 
Godoy et al., 2013), even though it is not nutritionally required by an adult cat and dog (NRC, 
2006). The inclusion of dietary fiber in pet food has a significant role in the management and 
mitigation of some diseases as well, since pets suffer from similar diseases that humans do. In 
companion animal nutrition, dietary fibers can be used to mitigate and/or prevent diseases such as 
diabetes (Blaxter et al., 1990; Nelson et al., 1991), gastrointestinal disorders (Tams, 1993), and 
obesity (German, 2006), and it can also contribute to intestinal health (Hooda et al., 2012), and 
glucose homeostasis (Massimino et al., 1998).   
  Both soluble and insoluble fibers may have beneficial physiological effects. There are three 
major mechanisms by which dietary fibers may exert physiological benefits: bulking, viscosity, 
and fermentation (Dai and Chau, 2016). Usually, insoluble dietary fibers provide a bulking effect, 
decrease intestinal transit time, increase stool mass, and alleviate constipation (Dai and Chau, 
2016; Renteria-Flores et al., 2008). This effect is due to the physical presence of insoluble fibers 
in the intestinal tract, which can hold water inside the fiber matrix (Dai and Chau, 2016). On the 
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other hand, soluble fibers may have a high rate and extent of fermentation in the intestinal tract, 
promoting the growth of intestinal microbiota and production of their byproducts such as short-
chain fatty acids (SCFA; Dai and Chau, 2016; Fahey et al., 2004). The insoluble to soluble fiber 
ratio must be considered when dietary fibers are included in monogastric diets, since their ratio 
can affect the rate of fermentation, and concentrations of fermentative end-products produced, 
such as  SCFA, branched-chain fatty acids (BCFA), and putrefactive compounds (i.e., phenols, 
indoles, ammonia; Dai and Chau, 2016).    
 
DIETARY FIBER IN CANINE NUTRITION 
The fact that dogs are capable of fermenting a significant amount of dietary fiber is broadly 
accepted. Research has highlighted that added fiber might improve intestinal and host health. 
Traditional sources of dietary fibers used in pet foods include beet pulp and cellulose (de Godoy 
et al., 2013), and these sources will be the focus of this review. Cellulose is composed of a 
relatively non-fermentable, insoluble and non-viscous fiber whereas beet pulp is comprised of a 
moderate fermentable fiber with both viscous and non-viscous components (Sunvold et al., 1995a; 
Fahey et al., 1990a; de Godoy at al., 2013). Considerable variation can occur in plant by-products 
due to alterations in factors such as soil and environmental conditions during growth, maturity at 
harvest, harvest date, plant parts included, and preparation of plants; these factors can interfere 
with their physical properties and fermentability (de Godoy et al., 2013). Beet pulp can be variable 
in macronutrient composition, but it often is high in pectin, cellulose and hemicelluloses 
(Titgemeyer et al., 1991; de Godoy et al., 2013). Previous literature reported that beet pulp TDF 
concentrations varying from 57 % to 82.6 % (Fahey et al., 1990a; Fahey et al., 1992; Sunvold et 
al., 1995a,b,c,d; Fischer et al., 2012; Kerr et al., 2013). On the other hand, cellulose is highly pure 
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and less variable, with TDF concentrations varying from 91.6 to 99.9 % (Sunvold et al., 1995a,b,c; 
Swanson et al., 2002b; Fischer  et al., 2012; Kerr et al., 2013) and being mainly insoluble.   
  Fahey et al. (1990a) evaluated the optimal level of beet pulp inclusion in a meat-based dog 
diet, as well as its effects on fecal excretion responses and mean retention time in the 
gastrointestinal tract of dogs. In that experiment, thirty female English Pointers were randomly 
assigned to isonitrogenous diets containing 0, 2.5, 5.0, 7.5, 10.0, or 12.5% beet pulp. Dogs 
accepted diet containing all inclusion levels. The beet pulp used contained 76.8% TDF, 16% 
viscous polysaccharides, 31.4% hemicelluloses and non-viscous polysaccharides, and 25.4% 
cellulose. This effective complement of viscous and non-viscous components allows beet pulp to 
be a moderately fermentable fiber. Fahey et al. (1990a) reported that mean retention time tended 
to decrease linearly (P < 0.06) with increasing dietary concentrations of beet pulp, suggesting that 
moderately to extensively fermentable fibers may decrease intestinal transit time. They also 
suggested that increasing beet pulp concentrations up to 12.5% in the diet slightly decreased ATTD 
of dry matter (DM), organic matter (OM), and ether extract by 6.8, 6.2, and 8.4%, respectively, 
compared to the control diet. The lower  ATTD observed was probably due to the decrease in 
intestinal retention time. However, they concluded that beet pulp can be utilized in extruded diets 
with an inclusion level up to 7.5% (12.0% TDF in this experiment) with no severe reduction in 
nutrient digestibility or energy utilization. Since then, 7.5% of beet pulp has been used as a positive 
control in other experiments and compared against other fiber sources.   
Other researchers evaluated the effects of dietary fibers on the digestibility and/or 
fermentability of other dietary ingredients. Muir et al. (1996) studied the effects of dietary fibers 
with different fermentation characteristics on nutrient digestion at the distal ileum and in the total 
tract of dogs. Dogs were assigned to and fed five different diets, which consisted of a basal high-
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protein (34%) and high-fat (23%) diet with one of the following supplementation: 1) a control 
treatment with 0% supplemental fiber (2.6% TDF); 2) 7.5% beet pulp (8.6% TDF); 3) low-
cellulose mixture: 2.5% cellulose + 5.0% pectin (9.7% TDF); 4) high-cellulose mixture: 5.0% 
cellulose + 2.5% pectin (9.7% TDF); or 5) 7.5% cellulose (8.7% TDF). Five female dogs were 
fitted with simple T-type ileal cannulas, since a precise estimate of nitrogen and amino acid 
digestibility can be obtained using dogs cannulated at the distal ileum. Muir et al. (1996) reported 
no differences in apparent ileal digestibilities of DM, OM, crude protein (CP), TDF, gross energy 
(GE), or amino acids among all diets. However, ATTD  of DM (82.5%), OM (84.6%), and GE 
(86.4%) were lower (P < 0.05) for dogs consuming the fiber-containing diets compared to the 
control diet (i.e., 85.3, 90.9, amd 91.1%, respectively). Also, ATTD of DM and GE decreased as 
the level of dietary cellulose increased and ATTD of OM was greater in beet pulp-containing diets 
compared to the other fiber-containing diets. These differences were attributed to the higher 
concentration of soluble fiber in the beet pulp diets compared to the cellulose diets. In addition to 
that, ATTD of TDF was greater (P < 0.05) for dogs fed beet pulp-containing diets compared with 
the other fiber treatments, indicating that soluble fibers are better energy substrates for 
gastrointestinal microorganisms than insoluble fibers. In  2007, Middelbos et al. also reported that 
dogs fed diets containing 2.5% cellulose had lower (P < 0.05) ATTD of DM, OM, and GE 
compared to diets containing 1% of cellulose or 2.5% beet pulp. The fact that cellulose had a 
negative impact on the digestibility of some macronutrients was not surprising, since cellulose has 
a low digestibility and fermentability rate, passing through the gastrointestinal tract relatively 
intact (de Godoy et al., 2013).   
  Depending on the dietary fiber macronutrient composition and its concentration in the diet, 
it may have numerous physiological effects on the body. The fermentability of the fiber source can 
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affect food intake, intestinal transit time, nutrient absorption, fecal volume, and intestinal 
microbiota populations (Zentek, 1996; Fahey et al., 2004). However, the main end-products of the 
fiber fermentation are SCFA (Fahey et al., 2004), which have been shown to have a trophic effect 
on the colonic mucosal, stimulate mucosal growth in the ileum, and increase mucosal DNA in the 
jejunum (Kripke et al., 1989). Sunvold et al. (1995c,d) suggested that dietary supplementation of 
fermentable fibers increased in vitro and in vivo fermentation of fibrous substrates by fecal 
microbiota from dogs, resulting in an increased concentration of SCFA in the large bowel. Sunvold 
et al. (1995c) conducted two experiments to evaluate single sources and blends of dietary fibers in 
dog foods. First, 14 fibrous substrates were fermented in a 24-hour in vitro system using dog feces 
as the source of inoculum; measurements were taken at 6, 12 and 24 hours. After 24 hour of 
fermentation, the OMD was lowest (P < 0.05) for cellulose (4.3%) and intermediate for beet pulp 
(38.2%); acetate, propionate, and butyrate production were also lowest (P < 0.05) for cellulose, 
being 0.09, 0.05, and 0.00 mmol/g of OM, respectively; acetate and propionate production were 
intermediate (P < 0.05) for beet pulp (2.03 and 0.80 mmol/g of OM, respectively), and butyrate 
production was greatest (P < 0.05) (0.70 mmol/g of OM).  Second, Sunvold et al. (1995c) used 
results of experiment one and formulated and fed dogs diets containing either different fiber blends 
or added beet pulp or cellulose as individual sources of fiber, since they vary in fermentability; 
fiber sources were added to the diets to provide approximately 7.5% supplemental TDF. Dogs fed 
diets containing beet pulp as the primary fiber source had greater (P < 0.05) ATTD of TDF (29%) 
compared to those fed diets containing cellulose (11%). In addition, ATTD of nitrogen of dogs fed 
beet pulp was lower (P < 0.05; 83.6%) compared to dogs fed cellulose (89.8%). Wet feces output 
was higher (P < 0.05) for dogs consuming the beet pulp diet, denoting the water-holding capacity 
of this fiber source (Serena et al., 2008).  
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In another experiment, Sunvold et al. (1995a) evaluated the fermentability of four fibrous 
substrates (i.e., cellulose, beet pulp, citrus pulp, and citrus pectin) by in vitro fermentation using 
dog fecal inoculum. A 48 hours fermentation period was completed, with measurements taken at 
6, 12, 24, and 48 hours. After 48 hours fermentation, cellulose had the lowest (P < 0.05) total 
SCFA production (0.08 mmol/g), followed by beet pulp (5.28 mmol/g), citrus pulp (5.52 mmol/g), 
and citrus pectin (6.16 mmol/g). Interestingly, the TDF concentrations (DM basis) for cellulose, 
beet pulp, citrus pulp, and citrus pectin were 91.6, 68.4, 70.2, and 66.3%, respectively, and the 
percentages of insoluble fiber for these fibrous sources were 99.4, 80.5, 54.4, and 2.3%, 
respectively; thus, soluble fiber content was positively associated with SCFA production. At 48 
hours, OMD of cellulose was the lowest (P < 0.05; 0.06%), followed by beet pulp (52.4%), citrus 
pulp (60.3%), and citrus pectin (86.0%). As expected, the higher percentage of soluble fiber 
resulted in greater OMD, supporting the influence of this fiber characteristic on fermentability and 
SCFA production. Muir et al. (1996) also evaluated SCFA concentrations in both the ileal digesta 
and  feces. Total ileal SCFA were higher (P < 0.05) in beet pulp-containing diets compared to the 
other treatments. However, averaged across treatments, ileal pH (7.23) was not affected by 
treatment, indicating a low microbial fermentation in the small intestine. Propionate concentrations 
tended to be lower (P < 0.10) for cellulose treatments compared to beet pulp treatments. 
Not only the percentage inclusion of dietary fiber but also its source should be considered 
as related to canine nutrition. Different physiological benefits can be achieved depending on the 
type, amount, and (or) blends of dietary fibers used in the diets formulations. Moreover, the 
variation within the same fiber source cannot be forgotten and must be accounted for when an 
optimal inclusion of dietary fiber is desired. Also, the role of dietary fiber in clinical diets must 
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also be studied, since diabetes and obesity are increasing in the pet population, and dietary fibers 
might play an important role in preventing or ameliorating these diseases.  
 
PREBIOTICS: DEFINITION AND CLASSIFICATION 
In 1995, the concept of prebiotics was first suggested by Gibson and Roberfroid as a “non-
digestible food ingredient that beneficially affects the host by selectively stimulating the growth 
and/or activity of one or a limited number of bacteria in the colon, improving host health”. The 
positive effects on health outcomes attracted much attention from the scientific and industrial 
fields, and many foods items started to be classified as prebiotics without fitting the criteria, 
especially many oligosaccharides and polysaccharides (Gibson et al., 2004). Thus, Gibson et al. 
(2004) established clear criteria for classifying a food ingredient as a prebiotic: “such classification 
required a scientific demonstration that the ingredient: (1) resisted gastric acidity, hydrolysis by 
mammalian enzymes, and gastrointestinal absorption; (2) were fermented by the intestinal 
microbiota; and (3) stimulated selectively the growth and/or activity of intestinal bacteria 
associated with health and wellbeing”. In addition, it was established that the final scientific test 
should be done in vivo in the targeted species. Prebiotics do not necessarily need to be completely 
indigestible; however, a significant amount must escape to the large bowel to be fermented by the 
intestinal microbiota and stimulate the growth and/or activity of beneficial bacteria (Roberfroid, 
2007a). Prebiotics need to be available to serve as a nutrient for beneficial microorganisms present 
in the host and, according to Gibson et al. (2017), prebiotics should not be broadly metabolized, 
but instead they should stimulate metabolism of health-promoting microorganisms.     
  Since 1995, the definition of prebiotics has evolved considerably and the need for a 
consensus definition was evident. Thus, the International Scientific Association for Probiotics and 
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Prebiotics (ISAPP) consensus panel redefined the prebiotic term as “a substrate that is selectively 
utilized by the host microorganisms conferring a health benefit” (Gibson et al., 2017). The criterion 
of “selective utilization” is mandatory, since it differentiates prebiotics from other substances, such 
as dietary fibers. Both dietary fibers and prebiotics are resistant (partially or totally) to digestion 
and are fermented by the gut microbiota, which can influence its composition; however, prebiotics 
have a selectivity that dietary fibers do not have (Roberfroid et al., 2010). Previously, selectivity 
was mainly related to stimulation of bifidobacteria and lactobacilli, but now the concept has 
expanded, and it does not need to be limited to these bacteria. According to Gibson et al. (2017), 
selective utilization does not mean prebiotics need to be utilized by just one group of 
microorganism, but means that it should not be utilized by all microorganisms. Prebiotics can 
cause a large specific shift in the gut microbiota population and direct carbon flux from 
carbohydrate substrates to metabolic end-products like organic acids (Rastall and Gibson, 2015). 
The main organic acids produced are SCFA, which are crucial for intestinal health; acetate, 
propionate, and butyrate account for 95% of the SCFA produced (Sunvold et al., 1995c).    
  Dietary prebiotics proven to induce health benefits in humans and animals are the non-
digestible oligosaccharides, fructans [i.e., fructooligosaccharides (FOS) and inulin] and galactans 
[i.e., galactooligosaccharides (GOS); Gibson et al., 2017]. Fructans are non-digestible 
oligosaccharides that are natural components of several edible fruits and vegetables, such as wheat, 
onions, bananas, garlic, and leeks (Roberfroid, 2007b). The most common plant used for the 
extraction of inulin-type fructans is chicory (Roberfroid, 2007b). Both FOS and GOS can be 
readily degraded by the enzymes, ß-fructanosidase and ß-galactosidase, respectively, which are 
prevalent in bifidobacteria (Gibson et al., 2017). Another example of a prebiotic used in companion 
animal diets is mannanoligosaccharides (MOS), component of Saccharomyces cerevisiae cell wall 
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(Grieshop et al., 2004). Vickers et al. (2001) conducted an in vitro fermentation experiment using 
dog feces as the inoculum to compare the fermentation characteristics of four inulin products, all 
of which are sources of FOS, one additional FOS source, a source of MOS, soy fiber, beet pulp 
(positive-control sample), and wood cellulose (negative-control sample). All substrates increased 
production of SCFA; however, total SCFA were greater (P < 0.05) for fermentation of the four 
inulin products and FOS (3.1 to 3.6 mmol/g of OM), than MOS (1.44 mmol/g of OM) and soy 
fiber (1.0 mmol/g of OM). Inulin and FOS produced the highest concentrations of acetate, 
propionate, and butyrate. The pattern and end-products of fermentation of the four inulin products 
and FOS were very similar, since these substrates had comparable chemical compositions. 
Although MOS is a non-digestible oligosaccharide, its prebiotic effect also has been attributed to 
the fact that it facilitates antigen presentation and thereby the shift from an innate to an adaptive 
immune response (Halas and Nochta, 2012). In this process, MOS is able to act as a high affinity 
ligand and attach to pathogens with the mannose-specific Type-1 fimbriae, preventing those 
pathogens from attaching to and colonizing the intestinal epithelial cells (Ofek et al., 1977).  
 
PREBIOTICS IN CANINE NUTRITION 
Currently, use of pro- and prebiotics is a common practice to promote the gut health in 
commercial pet foods. Prebiotics are used in order to modulate the gut microbiota, and thus, 
microbial activity and its end-products. Microbial fermentation of non-digestible carbohydrates is 
important for intestinal health, as its end-products are the SCFA, which play an important role 
serving as an energy source for colonocytes (especially butyrate), decreasing luminal pH (which 
creates an environment less favorable for pathogenic species), and modulating intestinal gene 
expression (Roediger, 1982; Swanson et al., 2002b; Swanson and Fahey, 2006). When it comes to 
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modulating gut microbiota and its activity, prebiotics are often considered advantageous compared 
to probiotics because after the food processing their viability and efficiency are higher than 
probiotics (Pawar et al., 2017). Several studies have evaluated the effects of prebiotic 
supplementation in dog foods, comparing different prebiotic types and dosages. Important aspects 
that are commonly evaluated in prebiotic experiments are food intake and fecal characteristics, 
macronutrient digestibility, gut microbial populations, and fecal concentrations of SCFA and 
putrefactive compounds. Inulin, FOS, and MOS are the most common prebiotics used in 
companion animal foods, thus, they will be the focus of this review.  
  In 2000, Strickling et al. evaluated the effects of dietary supplementation of FOS and MOS 
at 5g/kg of diet on ileal and ATTD of DM and nitrogen; ileal or fecal ammonia and SCFA 
concentrations; blood glucose concentrations; ileal pH, and fecal consistency. Those authors 
concluded that the addition of FOS or MOS at 5 g/kg did not affect any of these parameters, 
resulting in similar values between prebiotic supplementation and the control diet with no 
oligosaccharide added. They also suggested that a higher dosage of these prebiotics should be used 
to elicit a physiological response. Likewise, Beynen et al. (2002) evaluated the effects of 1% FOS 
on nitrogen excretion and mineral absorption in adult dogs. They reported no changes in these 
parameters, even though the initial hypothesis was that dietary supplementation of FOS could 
reduce fecal excretion of ammonia and nitrogen, since FOS can trap the nitrogen in the form of 
bacterial protein, thus lowering ammonia absorption.  
In contrast with previous literature, supplementation of FOS (2 g/d) and Lactobacillus 
acidophilus (probiotic; 109 CFU) together, or each indivually was tested in the diets of healthy 
adult dogs. Dogs consuming the FOS diet had lower (P < 0.05) fecal output, which was attributed 
to increased microbial activity resulting from FOS supplementation. Dogs supplemented with FOS 
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also had greater concentrations of fecal lactate (P < 0.05) and butyrate (P < 0.05) compared to 
dogs fed the sucrose control. An increased production of lactate, which is the major end-product 
of Lactobacillus spp. and Bifidobacterium spp., can cause a decrease in the luminal pH and thus 
protect the gut from pathogenic species. In addition, putrefactive compounds such as BCFA, 
phenol, and indole were lower in dogs fed FOS (Swanson et al., 2002a).  
Another study from the same group of researchers examined the effects of FOS and/ or 
MOS supplementation on nutrient digestibility, immune function, and protein catabolite 
concentrations in the feces of dogs. Similar to these previous studies, the authors reported no 
differences in ileal or ATTD of DM, OM, and CP among any of the dietary treatments [i.e., 1) 
Control (no supplementation); 2) 1 g FOS; 3) 1 g MOS; and 4 ) 1g FOS + 1 g MOS]. Similarly, 
FOS and MOS did not affect fecal characteristics, including fecal pH (Swanson et al., 2002b). In 
the same experiment, dogs fed FOS or MOS had no differences in fecal SCFA or BCFA compared 
to the control diet. However, total fecal phenol and indole concentrations were lower for dogs 
supplemented with FOS (P < 0.05) and FOS + MOS (P < 0.05) compared to control. MOS-fed 
dogs also showed potential benefits to the immune system after supplementation, such as a greater 
(P < 0.05) proportions of serum lymphocytes compared to control dogs and a tendency (P = 0.135) 
to increased serum IgA concentrations (Swanson et al, 2002c). However, Zentek et al. (2002) 
reported decreased digestibility of DM, CP, and nitrogen-free extract by dogs fed diets 
supplemented with 5.9% MOS. Those researchers also showed that dogs receiving MOS had lower 
fecal pH and ammonia concentrations. Differences in MOS dosages among these studies likely 
were the cause of the discrepancies in results reported by those authors.  
Moreover, Hesta et al. (2003) investigated the effects of supplementing FOS at 3% of a 
maintenance dog diet enriched with animal protein sources (up to 50% of CP on an as-fed basis) 
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on ATTD of macronutrients. They reported a decrease in ATTD of DM and acid hydrolyzed fat 
(AHF) after addition of 3% FOS. Also, adding oligosaccharides to the protein-supplemented diets 
not only decreased ATTD of N, but also increased the bacterial N content of the feces. However, 
when N digestibility was corrected for bacterial N, there were no differences between the control 
and the FOS groups, which indicated that the lower total tract N digestibility was not a 
consequence of a lower small intestinal digestibility but rather due to the higher fecal N content 
originating from bacteria in the large intestine. Bacterial N content (% DM) in dog feces was 
greatest (P > 0.05) in the FOS groups followed by the protein-supplemented groups and lowest in 
the control groups. Supplementation of FOS did not affect fecal pH or decrease fecal ammonia 
concentrations of dogs, similar to previous findings reported by Zentek et al. (2002) and Swanson 
et al. (2002a,c).  
Variable results among experiments may be explained by use of different dosages of 
prebiotics. Flickinger et al. (2003) performed two experiments to examine the effects of different 
low concentrations of fructans on nutrient digestibilities, end-products of protein fermentation, and 
fecal characteristics of healthy adult dogs. In the first experiment, dogs consumed a diet with 0.6% 
dietary inulin. They reported a lower (P < 0.05) ATTD of DM, OM, and AHF in inulin-
supplemented dogs; ATTD of CP tended (P = 0.07) to be lower for these dogs compared with 
unsupplemented animals. Propst et al. (2003) also reported decreased ATTD of DM, OM, and CP 
as a result of dietary inclusion of inulin at 0.3, 0.6 or 0.9% DMB. Fecal characteristics were not 
affected by inulin supplementation, indicating no adverse effects of inclusion of inulin in the diet 
at up to 0.6% (DM basis). Fecal propionate concentrations were increased (P < 0.05) and fecal 
concentrations of butyrate and total SCFA tended to be greater (P = 0.15 and 0.07, respectively) 
in feces of supplemented compared to non-supplemented dogs. However, putrefactive compounds 
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were not different among treatments. In the second experiment conduced by Flickinger et al. 
(2003), ileally cannulated adult dogs were used to test three concentrations of FOS (1, 2, and 3 
g/d), which was administered orally by gelatin capsules. Supplementation of FOS tended (P < 
0.15) to linearly increase ileal digestibilities of DM, OM, CP, and AHF. However, ATTD of DM, 
OM, and CP did not differ due to FOS supplementation. Fecal characteristics remained unchanged, 
except for fecal pH, which was the highest (P < 0.05) in dogs receiving 1g/d FOS and lowest in 
dogs receiving either 0 or 3 g/d FOS. They also reported that fecal putrefactive compounds and 
SCFA concentrations were not affected by FOS supplementation.  
The possibility of a synergic effect between inulin and MOS has also been examined. 
Grieshop and coworkers (2004) used chicory as a source of inulin (chicory root contains 
approximately 55% inulin) and MOS, together or alone, to evaluate possible changes in 
immunological parameters in senior dogs. The treatments used were: 1) no supplementation 
(control); 2) 1% dietary chicory; 3) 1% dietary MOS and 4) 1% chicory + 1% MOS. Those authors 
reported an increase in food intake of dogs fed MOS or combination of MOS + chicory, which 
was not expected nor previously reported in experiments using MOS (Swanson et al., 2002b). 
Chicory alone did not affect food intake in this experiment, but an increase in food intake after 
inulin supplementation was later reported for overweight dogs by Alexander et al. (2018). Fecal 
score in all treatment groups remained ideal. Further, Grieshop et al. (2004) also reported no 
differences in ATTD of DM, OM, or CP among treatments. Supplementation of MOS and/or 
chicory appeared to have no significant effects on serum immunoglobulin; however, the 
combination of MOS + chicory and chicory alone tended to increased (P = 0.10) neutrophil 
concentrations by 20% compared with control dogs (5.0 cells x 103/µl). Middelbos et al. (2007) 
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also reported no significant difference on immune indices such as white blood cell counts or 
immunoglobulin concentrations after supplementing dogs with 0.9, 1.2 or 1.5% FOS.  
Recently, Alexander et al. (2018) evaluated the effects of inulin supplementation by 
overweight dogs. Nine adult beagles were fed the same experimental diet and supplemented with 
gelatin capsules with inulin. The treatments used were: placebo (cellulose – non-prebiotic effect), 
0.5 or 1% inulin added to the diet. Dogs fed 1% presented the greatest (P < 0.05) concentrations 
of fecal total SCFA, acetate, butyrate, and propionate, compared to the other groups. Also, fecal 
pH and scores were not different among treatment groups, and the scores were within the ideal 
range. Fecal putrefactive compounds also were not affected by inulin supplementation. These 
findings are in agreement with Verlinden et al. (2006) who reported that  supplementation of  3% 
inulin to extruded hypoallergenic diet did not alter fecal pH, food and water intake. Even though 
fecal moisture was higher in dogs that received inulin, the fecal score remained the same and was 
within the ideal range.  
After analyzing the data from the studies referenced above, there is sufficient evidence to 
conclude that overall, the use of FOS, MOS, and inulin do not appear to have detrimental effects 
on stool consistency or volume, an important criterian when pet parents are choosing a food. 
Prebiotic supplementation may result in greater wet fecal volume, however fecal scores typically 
remain within an ideal range. In addition, prebiotics may have a small detrimental effect on 
macronutrient digestibility, but it does not appear to compromise the nutritional value of the food. 
Lower ATTD of CP can be overestimated after supplementation with prebiotics, since its 
supplementation often increases bacterial mass (and, thus, N) concentrations. Prebiotics also 
modulate fecal metabolites, decreasing some putrefactive compounds and increasing SCFA 
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concentrations in feces. The effects of prebiotics on gut microbiota will be discussed later in this 
chapter.  
 
GUT PROMOTERS IN CANINE NUTRITION 
Dietary supplementation of gut promoters has not been studied to any extent in canine 
nutrition. The scientific literature on this topic is scarce, but the use of dietary additives such as 
anise oil, eugenol and sweetener has been evaluated in poultry and swine nutrition. For example, 
anethole is one of the main constituents of Croton zehntneri, an aromatic bush native to 
northeastern Brazil (Coelho-de-Souza et al., 2012), and has been shown to exhibit antimicrobial 
activity against bacteria and fungi (Hitokoto et al., 1980; Yutani et al., 2011; Fujita et al., 2017). 
Coelho-de-Souza and coworkers (2012) studied the effects of anethole on gastric lesions in rats. 
Authors reported that the use of anethole at doses of 30–300 mg/kg had a gastroprotective effect 
against ethanol- and indomethacin-induced gastric damage. In addition, authors reported that 
anethole appeared to increase (P < 0.05) gastric mucus production, which is an important 
gastroprotective factor.  
Anethole is also present in anise oil, representing 90% of the oil. Dietary supplementation 
of anise oil on laying hens enhanced laying performance and overall antioxidant status (Yu et al., 
2018). In addition, Charal et al. (2017) conducted experiments in broilers to evaluate the effective 
dosage of anise oil during C. perfringens challenges. The study consisted of four experiments of 
different lengths, but all were conducted with one-day-old male Ross 708 broilers. The positive 
control received an antibiotic (bacitracin methylene disalicylate) and anticoccidial (salinomycin 
sodium) and treatment consisted of three diets containing 500, 1,000, or 1,500 mg/kg anise oil. 
The authors reported that feeding broilers anise oil at dosages lower than 1,500 mg/kg should not 
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affect their weight gain and food intake. Also, anise oil-supplemented broilers showed lower (P > 
0.05) jejunal lesions than the positive control animals, indicating a reduction in bacterial counts or 
bacterial adhesion to the intestinal lumen. Thus, the authors concluded that anise oil can be an 
alternative to the use of antibiotics fed as growth promotants for chickens.  
The use of eugenol, another polyphenol compound that is the major antimicrobial 
component present in the oil of cloves (Syzgium aromaticum), has also been studied. Eugenol has 
been shown to exert both antimicrobial and anti-inflammatory properties (Friedman et al., 2002; 
Kim et al., 2003). Upadhyay  et al. (2017) evaluated the effects of eugenol in a culture of human 
intestinal epithelial cells (Caco-2) and reported that the use of eugenol reduced (P < 0.05) C. jejuni 
attachment, invasion, and translocation of human intestinal epithelial cells. Additionally, Thapa et 
al. (2012) also tested the influence of eugenol on the growth of cultured pathogenic and commensal 
bacteria, and reported that eugenol was more effective in suppressing the growth of some 
pathogenic bacteria such as E. coli, S. typhimurium and C. difficile, compared to some commensal 
species such as L. plantarum, Eu. hallii and B.. adolescentis.  
The use of an artificial sweeteners has been evaluated in weaned pigs by Daly et al. (2014). 
They studied if dietary supplementation of an artificial sweetener would interfere with the 
microbiota of piglets, especifically on the abundance of caecal Lactobacillus, even though the 
mechanism(s) by which artificial sweeteners would act are presently unknown. The treatment 
tested contained 0.015% of an artificial sweetener consisting of saccharin and neohesperidin 
dihydrochalcone (SUCRAM®, Pancosma, SA) and was supplemented to piglets for 2 weeks. The 
authors used 16S rDNA based 454 pyrosequencing technology and determined a dramatic increase 
in the caecal population abundance of Lactobacillus spp.; lactic acid also was increased in the 
treatment group.  
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Further studies evaluating the effects of artificial sweeteners and eugenol on canine gut 
health may be beneficial. Not only might they modulate the gut microbiome, but also may serve 
as a stimulus for mucus production and aid in the protection of the gastrointestinal tract.   
 
THE IMPORTANCE OF THE GUT MICROBIOTA 
The gut microbiota is a large and diverse group of microorganisms that play significant 
roles in health and disease of the host (Redfen et al., 2017; Feng et al., 2018). It is comprised of a 
large and diverse population of microorganisms that include archaea, bacteria, fungi, protozoa and 
viruses, but bacteria are the major constituent of the microbiota (Redfen et al., 2017; Feng et al., 
2018). A recent calculation estimates that there are 1013 bacteria cells in the body, which is 
equivalent to the number of human cells (Sender et al., 2016). These microorganims influence the 
overall health of the host, playing an important role in gastrointestinal and systemic immunity, in 
the production of SCFA, and in modulating the expression of genes associated with important 
physiological functions (Swanson and Fahey, 2006). Advances in sequencing technologies have 
allowed for the quantification, isolation, and characterization of the gut microbial community. The 
detection of a different microbiota between healthy and diseased subjects has caught the attention 
of the scientific community, and has led to the conclusion that modifying the gut microbiota might 
be beneficial to host health in some circumstances (Schmitz and Suchodolski, 2016).  
The host and the microorganisms live in a mutualistic relationship since the microbiota 
contribute to many aspects of host physiology such as fermentation of carbohydrates and 
production of substances such as SCFA and vitamins (K, B9, B12), protection against pathogens, 
development of gut-associated lymphoid tissues, and help in host immune modulation. In 
return, the host provides niches and nutrients for microbial survival (Honda and Littman, 2012; 
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Kamada et al., 2013; Redfern et al., 2017). These important functions of the gut microbiota can 
be impaired with bacterial dysbiosis, which is defined as “an alteration in the composition 
and/or richness (i.e., the number of unique bacterial species) of the intestinal microbiota” 
(Suchodolski, 2016).  
The use of fiber and pro- and prebiotics has been the focus of much attention as regards 
modulation of the gut microbiota towards a healthier community. The predominant bacterial 
groups that have been cultured from canine and feline intestines are Bacteroides, Clostridium, 
Lactobacillus, Bifidobacterium spp, and Enterobacteriaceae (Suchodolski, 2011), even though 
each animal harbors a unique microbial profile (Suchodolski et al., 2005). The microbiota can 
interact directly with the host cells, or it can influence them through microbial metabolites, 
which can be produced either directly or indirectly by the bacteria (Suchodolski, 2016). 
Bifidobacterium and Lactobacillus are believed to be important producers of metabolites that have 
a direct beneficial impact on host health (Gibson and Roberfroid, 1995; Suchodolski, 2016).  
The amount and type of fermentable carbohydrate that arrives in the human colon is one 
of the primary factors that limits the growth of the resident bacterial population (Cummings and 
Macfarlane, 1991). However, the gut microbiome is extremely complex and not all bacteria are 
able to digest the same substrates; thus, microbes interact in a way whereby the products of one 
strain may be further utilized by another. This exchanging of metabolites between microbes is 
referred to as cross-feeding (Smith et al., 2018). Because of the diversity and metabolic capabilities 
of the microbiota, gut fermentation is a complicated process and cannot always be well controlled. 
In most cases, the metabolic end-products excreted by one individual species can serve as a growth 
substrate for another (Fava et al., 2018; Smith et al., 2018). Both Bifidobacterium and 
Lactobacillus are saccharolytic bacteria, performing fermentation of carbohydrates in the proximal 
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part of the colon and producing beneficial end-products such as SCFA (Fava et al., 2018; Rowland 
et al., 2018). On the other hand, proteolytic fermentation appears to be located in the distal region 
of the large intestine and results in the production of end-products considered harmful for the host, 
such as amines, ammonia, sulfides, and indoles (Fava et al., 2018).  
Use of nutritional approaches that can shift the gut microbiota profile, increase fecal 
fermentative end-products from saccharolytic degradation, and decrease proteolytic fermentative 
end-products, has gained increased attention in the past couple decades. Modulation of the canine 
gut microbiome utilizing prebiotics and dietary fibers has been investigated and will be discussed 
next.  
 
MODULATION OF THE CANINE GUT MICROBIOTA BY PREBIOTICS AND 
DIETARY FIBERS 
A few studies have investigated the effects of prebiotics and dietary fibers on the gut 
microbiota of dogs. According to Schmitz and Suchodolski (2016), there are some limitations in 
these data, since most studies used plating techniques or qPCR to quantify a limited number of 
bacteria, mostly in healthy dogs, thus limiting the inference of the results to diseased populations. 
In addition,  analysis of fecal samples rather than mucosal biopsies or digesta, and use of a wide 
range of prebiotic dosages makes direct  comparisons among datasets impossible. In vitro and in 
vivo studies evaluating the fermentative profile of dietary fibers and the resulting fecal metabolites 
were discussed previously. There is limited literature evaluating the effects of beet pulp and/or 
cellulose on the dog gut microbiota. Thus, the focus of this review will be to discuss the effects of 
prebiotics, such as FOS, MOS, and inulin, on the canine gut microbiome.  
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In 2000, Strickling et al. evaluated the effects of dietary supplementation of FOS and MOS 
at 5 g/kg of diet DM on bacterial concentrations. Fecal and ileal samples were cultured for specific 
bacteria: C. perfringens, bifidobacteria, E. coli and total coliforms, lactobacilli, and anaerobes. 
There were no effects of dietary oligosaccharide supplementation on any of the bacterial colony 
forming units (CFU) plated from the ileal digesta. This is due to limited fermentation in the ileum. 
The incubation of fecal samples resulted in a tendency for lower growth (P = 0.09) of C. 
perfringens with MOS (4.48 log CFU/g DM) vs. FOS (4.78 log CFU/g DM) supplementation. No 
other significant differences were noted between control and oligosaccharide supplementation 
groups.  
Beynen et al. (2002) also evaluated fecal bacterial profile in adult dogs after three weeks 
of supplementation with 1% FOS, which resulted in daily intake of approximately 0.18 g FOS/kg 
BW/day. In this study, a fecal sample from each dog was obtained for culture and bacterial 
enumeration and identification. The results showed that total counts of anaerobic and aerobic 
bacteria and of streptococci, clostridia and bifidobacteria were significantly higher (P < 0.05) in 
feces of animals that received FOS. Other than the increase in bifidobacteria, these authors do not 
interpreted the other changes being beneficial or harmful.  
Swanson et al. (2002a) evaluated the effects of supplementation of 2 g FOS and/or 
Lactobacillus acidophilus (probiotic) on fecal microbial populations. Fresh fecal samples were 
collected within 15 minutes of defecation and transferred to a media container for subsequent 
plating and bacterial enumeration. Authors reported that dogs supplemented with FOS had a 
greater number of total aerobes, bifidobacteria and lactobacilli in the gut, even though FOS 
represented <1% of the dietary intake. Also, dogs fed FOS tended (P = 0.08) to have decreased C. 
perfringens concentrations, which indicates better gut health. Furthermore, Swanson et al. (2002b) 
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evaluated the effects of supplementation of FOS and/or MOS on microbial populations in the large 
bowel of the dog. MOS-fed dogs tended to have greater fecal concentrations of lactobacilli 
compared to the control group. No differences in fecal concentrations of bifidobacteria, E. coli, or 
C. perfringens were found in dogs fed FOS or MOS.  
In another experiment testing FOS supplementation, Flickinger et al. (2003) used ileal 
cannulated dogs and treated them with gelatin capsules containing three different concentrations 
of FOS: 1, 2, or 3 g/day. After 18 days,  fresh fecal samples were collected within 15 minutes of 
defecation and transferred to the media for plating and bacteria enumeration. Authors reported that 
total anaerobes, bifidobacteria, and lactobacilli concentrations in feces were not altered by any of 
the FOS doses. However, total aerobe concentrations linearly increased (P < 0.05) with dose of 
FOS. Additionally, fecal concentrations of C. perfringens in dogs fed FOS (all concentrations) 
tended to decrease (P = 0.08) compared to the control group. In addition to supplementing dogs 
with FOS, Flickinger et al. (2003) also fed dogs a diet containing 0.6% dietary inulin. Neither fecal 
total anaerobe or bifidobacteria concentrations differed after inulin supplementation. However, 
total aerobe concentrations tended (P = 0.07) to be lower in the inulin supplemented group. 
Grieshop and coworkers (2004) tested chicory inulin and MOS, in combination or alone, 
to evaluate possible changes in fecal microbiota of senior dogs. The treatments used were: 1) no 
supplementation (control); 2) 1% dietary chicory; 3) 1% dietary MOS; 4) 1% chicory+1% MOS. 
They reported that fecal samples from dogs supplemented with either chicory or MOS alone had 
greater (P = 0.03) concentrations of fecal bifidobacteria compared to non-supplemented dogs. 
Interestingly, the combination of chicory with MOS was not effective in increasing the 
concentration of bifidobacteria compared to the control group. Also, fecal concentrations of 
lactobacilli did not differ among treatments.  
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Middelbos et al. (2007) evaluated the effects of blends of fermentable oligosaccharides in 
combination with nonfermentable fibers on gut microbiota of dogs. Adult dogs were fed one of 
the following diets: 1) control diet – no supplemental fermentable carbohydrate (1.5% TDF); 2) 
2.5% cellulose 3) 2.5% beet pulp; 4) 1.0% cellulose + 1.5% FOS; 5) 1.0% cellulose + 1.2% FOS 
+ 0.3% yeast cell wall; or 6) 1.0% cellulose + 0.9% FOS + 0.6% yeast cell walls. After 14 days of 
supplementation, fresh fecal samples were collected and were both transferred to a media container 
for subsequent bacterial enumeration and also placed into sterile cryogenic vials and frozen at 
−80°C until DNA extraction for microbial analysis that were performed using two methods: serial 
dilution and plating, and by DNA extraction from fecal samples, followed by quantitative PCR 
(qPCR) and denaturing gradient gel electrophoresis techniques. Using platting methods, 
bifidobacteria and total aerobic bacteria concentrations were greater (P < 0.05) in fecal samples of 
dogs supplemented with 1.0% cellulose + 1.5% FOS compared with dogs fed 2.5% cellulose. 
Additionally, total anaerobic bacteria concentrations were greater (P < 0.05) for the 1.0% cellulose 
+ 1.5% FOS treatment and for the 1.0% cellulose + 0.9% FOS + 0.6% yeast cell wall treatment 
compared with the cellulose treatment. Using qPCR methods, bifidobacteria concentrations were 
greater (P < 0.05) for the treatments supplemented with any of the fermentable substrates (i.e., 
beet pulp, FOS, or yeast cell wall). The treatments containing 1.0% cellulose + 1.5% FOS or 1.0% 
cellulose + 0.9% FOS + 0.6% yeast cell wall had greater (P < 0.05) lactobacilli concentrations 
compared with the cellulose treatment. Overall, the qPCR method was more effective in detecting 
treatment effects on bifidobacteria and lactobacilli compared with the plating method.   
More recently, Garcia-Mazcorro et al. (2017) evaluated the effects of a commercially 
available nutraceutical containing 225 mg FOS and inulin on the fecal microbiota of healthy dogs 
when administered once per day for 16 days. In a second trial, another group of dogs received 3.2 
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mL/kg BW (each mL containing 31 mg of FOS and inulin – 3.1% prebiotic). Fresh fecal samples 
were analyzed for total genomic DNA using primers targeting the 16S rRNA V4-V5 region. In the 
first trial these authors reported that differences were not sufficient to separate bacterial 
communities before and after the prebiotic administration. In the second trial, where higher doses 
of prebiotics were tested, the results revealed a lower abundance of Dorea (family Clostridiaceae) 
and a higher abundance of Megamonas and other members of Veillonellaceae during prebiotic 
administration; however, the changes were not sufficient to affect alpha and beta diversity from 
before and after the administration of prebiotics. Using the same analytical method, Alexander et 
al. (2018) also reported that neither fecal microbial species richness nor unweighted or weighted 
principal coordinate analysis plots of fecal microbial communities were significantly different after 
supplementation of 0.5% or 1% inulin to adult dogs. 
Finally, a recent study evaluated the effect of FOS (15 g/kg diet) on fecal microbiota of 
healthy adult dogs fed extruded diets formulated to have a high protein (304 g/kg DM) or low 
protein (229 g/kg DM) content. Fresh fecal samples were used for DNA extraction and qPCR of 
specific primers for total bacteria, E. coli, Bifidobacterium genus, Lactobacillus genus, 
Enterococcus genus, and C. perfringens. Most of the bacterial populations evaluated were not 
modified by dietary treatment; however, bifidobacteria showed a significant (P < 0.05) interaction 
between dietary protein content and FOS supplementation, indicating that FOS reduced 
Bifidobacteria in the low-protein diet, but increased this genus when FOS was supplemented in 
the high-protein diet (Pinna et al., 2018).  
A wide range of prebiotic dosages have been tested in the experiments conducted to data, 
as well as different methods for microbiota determination have been used. This makes inferences 
about prebiotic efficacy somewhat complicated. However, it is important to keep in mind that not 
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only modulation of gut microbial communities is important for a healthy animal, but also the 
modulation of microbial activity that could lead to increased beneficial effects on host health 
beyond shifts in microbial taxa. 
 
THESIS OBJECTIVES 
The aim of this research was to evaluate the effects of dietary supplementation of a fiber 
and prebiotic blend alone or in combination with a gut health promoter additive on gastrointestinal 
health indices of adult dogs through the determination of apparent total tract macronutrient 
digestibility, fecal characteristics, fermentative end-products, and fecal microbiota. 
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CHAPTER 3:  
DIETARY SUPPLEMENTATION OF A FIBER-PREBIOTIC-GUT HEALTH 
PROMOTER BLEND IN EXTRUDED DIETS FED TO DOGS 
 
ABSTRACT 
Prebiotics and dietary fibers are non-digestible ingredients that may confer benefits to the 
host by selectively stimulating beneficial intestinal bacteria and microbial-derived metabolites that 
support gut and host health. This experiment evaluated the effects of a blend of prebiotics and 
dietary fibers on apparent total tract digestibility (ATTD) and fecal metabolites related to 
gastrointestinal health in adult dogs. Four diets containing either 5% cellulose (control; CT), 5% 
dietary fiber and prebiotic blend (FP), 0.02% of a gut health promoter additive (GP), or 5% fiber 
blend plus 0.02% gut health promoter (FG) were formulated to meet or exceed the AAFCO (2017) 
nutritional requirements for adult dogs. Eight adult female beagles (mean age 4.2 ± 1.1 yr; mean 
BW = 10.8 ± 1.4 kg; mean BCS = 5.8 ± 0.6) were randomly assigned to one of the four dietary 
treatments using a replicated 4x4 Latin square design. Each experimental period consisted of 14 d 
(10 d of diet adaptation and 4 d of total and fresh fecal and total urine collection). Blood samples 
were collected at the end of each period for serum chemistry analysis and complete blood count. 
All animals remained healthy throughout the study, with serum metabolites being within reference 
ranges for adult dogs. All diets were well accepted by the dogs, resulting in similar (P > 0.05) daily 
food intakes among treatments. Likewise, fecal output and scores did not differ (P > 0.05) among 
dietary treatments, with the latter being within the ideal range (2.5-2.9) in a 5-point scale. All diets 
were highly digestible and had similar (P > 0.05) ATTD of dry matter (81.6-84.4%), organic matter 
(86.4-87.3%), and crude protein (86.6-87.3%). However, ATTD of total dietary fiber (TDF) was 
greater for dogs fed the FG  diet (P < 0.05) in contrast with dogs fed the GP and CT diets, while 
dogs fed the FP diets had intermediate TDF digestibilities but not different from CT, FG or GP.  
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Fecal acetate and propionate concentrations were greater (P < 0.05) for dogs fed FP and FG diets. 
Fecal concentrations of isobutyrate and isovalerate were greater for dogs fed CT (P < 0.05) 
compared to dogs fed the other three treatments. No shifts in fecal microbial richness and diversity 
were observed among dietary treatments. Overall, the data suggest that dietary supplementation of 
fiber and prebiotic blend were well tolerated by dogs, did not cause detrimental effects on fecal 
quality or nutrient digestibility, and resulted in beneficial shifts in fecal metabolites that may 
support gut health.  
Key words: dietary fiber, dogs, gut health, microbiota, and nutrient digestibility  
 
INTRODUCTION  
It is recognized that a nutritionally balanced diet and an appropriate microbial ecology are 
required for a healthy gut, as the latter assists with colon microenvironment homeostasis, immune 
system development, gut epithelial function, and systemic host health (Swanson et al., 2002a). As 
such, dietary strategies to support or maintain gut health maintained interest in both human and 
animal nutrition. Supplementation of prebiotics and dietary fibers have been a main focal point of 
research in this field for the past couple decades.  
Dietary fibers are heterogenous compounds and have different physiological benefits 
depending on their chemical structure and physical properties (e.g., viscosity, solubility, water-
holding capacity, fermentability; Schneeman, 1994). While there are a few definitions for dietary 
fibers, in 2016, the Food and Drug Administration (FDA) redefined dietary fiber as: “non-
digestible soluble and insoluble carbohydrates (with 3 or more monomeric units), and lignin that 
are intrinsic and intact in plants; isolated or synthetic non-digestible carbohydrates (with 3 or more 
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monomeric units) determined by FDA to have physiological effects that are beneficial to human 
health”.  
In 1995, Gibson and Roberfroid first defined a prebiotic as a “non-digestible food 
ingredient that beneficially affects the host by selectively stimulating the growth and/or activity of 
one or a limited number of bacteria in the colon, and thus improves host health”. Ingredients can 
be classified as prebiotics if they fit the following criteria: (1) resist gastric acidity, hydrolysis by 
mammalian enzymes, and gastrointestinal absorption; (2) are fermented by the intestinal 
microbiota; and (3) stimulate selectively the growth and/or activity of intestinal bacteria associated 
with health and wellbeing (Gibson et al., 2004). More recently, the term prebiotic has been 
redefined by the International Scientific Association for Probiotics and Prebiotics consensus panel 
as “a substrate that is selectively utilized by the host microorganisms conferring a health benefit” 
(Gibson et al., 2017). 
Dietary fibers and prebiotics also play an important role in the health of companion animals 
by modulating bowel movement, influencing immune function and gut microbiota profile, diluting 
caloric density, contributing to weight loss and, indirectly, ameliorating the incidence of obesity 
and diabetes mellitus in the pet population (de Godoy et al., 2013). Thus, the objective of this 
research was to evaluate the effects of dietary supplementation of a fiber and prebiotic blend alone 
or in combination with a gut health promoter additive on parameters related to gastrointestinal 
health of adult dogs through the determination of apparent total tract macronutrient digestibility, 
and fecal characteristics, metabolites, and microbial communities.  
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MATERIALS AND METHODS  
Animals and Experimental Design 
All animal procedures were approved by the University of Illinois Institutional Animal 
Care and Use committee prior to animal experimentation. Eight intact adult female dogs [mean 
age 4.2 ± 1.14 yr; mean body weight (BW) = 10.8 ± 1.38 kg; mean body condition score (BCS) = 
5.6 ± 0.63] were used in a replicated 4x4 Latin square design, so each animal served as its own 
control. Each experimental period consisted of 10 d of diet adaptation and 4 d of total fecal and 
urine collection. The dogs were housed in a temperature- and light-controlled room (14 h light: 10 
h dark) at the Veterinary Medicine Basic Sciences building at the University of Illinois at Urbana-
Champaign. Dogs were housed individually (1.2 m x 1.8 m) with nose to nose contact with dogs 
in adjacent runs and visual contact with all dogs in the room. Dog were socialized in groups at 
least twice a week with toy enrichment.  
Dogs were randomly assigned to one of the four experimental diets and were fed to 
maintain BW and BCS, which were measured once a week during the experimental period. Food 
intake was determined based on previous individualized food intake and metabolizable energy 
(ME) requirement records. Water was available ad libitum and feeding was done twice daily at 
0800 and 1600. Dogs had access to their assigned food until the next feeding time when food 
refusals, if present, were collected and recorded. During the collection phase, dogs were housed 
individually in metabolic cages, given the same access to food and water, and allowed individual 
social interaction daily. 
Diets 
 Four diets were used: 1) 5% cellulose (CT); 2) 5% fiber and prebiotic blend [containing a 
mix of cellulose, beet pulp, inulin, mannan-oligosaccharide (MOS), and fructo-oligosaccharide 
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(FOS); (FP)]; 3) 0.02% of a gut health promoter additive [composed of sweetener (SUCRAM®) 
and a phytomolecule (Eugenol); TAK TIK, Pancosma, Geneva, Switzerland; (GP)]; 4) 5% fiber 
and prebiotic blend plus 0.02% of the gut health promoter (FG). Diets were formulated to meet or 
exceed the AAFCO (2017) nutritional requirements for adult dogs. All four experimental diets had 
similar ingredient composition except for the fiber and prebiotic blend inclusion on the FP and FG 
diets, and the gut health promoter inclusion in the GP and FG diets (Table 3.1). 
Sample Collection 
Throughout the 4 d of total fecal and urine collections, all feces were collected and scored 
using the following 5-point scale: 1= hard, dry pellets; small hard mass; 2 = hard formed, remains 
firm and soft; 3 = soft, formed and moist stool, retains shape; 4 = soft, unformed stool; assumes 
shape of container; 5 = watery, liquid that can be poured. All individual fecal samples identified 
by dog and period were stored at -20℃ until analysis. Similarly, total urine output was collected 
simultaneously with fecal collections, into vessels containing 10 mL 2 N hydrochloric acid for 
immediate acidification of samples. The volume and weight of acidified urine samples were 
recorded and approximately 25% of each sample was saved and stored frozen. Composited urine 
samples by dog and period were stored in separate containers and kept at -20°C until analysis. 
Within the collection period, one fresh fecal sample from each dog was collected within 
15 min of defecation and analyzed for dry matter (DM), phenols and indoles, short-chain fatty 
acids (SCFA), branched-chain fatty acids (BCFA), and microbiota. A pH reading, fecal score, and 
total sample weight also were recorded. Dry matter was measured by drying approximately 2 
grams (g) of feces in duplicate in a 105°C oven until all moisture was removed. Approximately 2 
g of feces in duplicate were stored in plastic tubes covered in parafilm and frozen at -20°C for 
subsequent indole and phenol analyses. Finally, 5 g of sample were stored in Nalgene bottles 
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containing 5 mL of 2N hydrochloric acid and frozen at -20 °C to determine SCFA, BCFA, and 
ammonia concentrations. 
Additionally, after overnight fasting, 5 mL of blood were collected via jugular 
venipuncture from each dog at the end of each experimental period.  Serum separator and EDTA 
vacutainer tubes (Becton, Dickinson and Company, Franklin Lakes, NJ) were used for serum 
chemistry (4 mL) and complete blood count (1 mL) analyses, respectively. These analyses were 
conducted by the Clinical Pathology Laboratory at the University of Illinois College of Veterinary 
Medicine (Urbana, IL). 
Sample Preparation and Chemical Analyses 
 Food and fecal samples were used to determine apparent total tract digestibility (ATTD) 
of macronutrient digestibility. Fecal samples from each dog and period were pooled and dried at 
57°C in a forced-air oven before grinding in a Wiley Mill with a 10 mesh (2 mm) screen size and 
used for subsequent laboratory analyses. Diet samples were also ground in the same way for 
analysis. DM, organic matter (OM), and ash were determined for the diets and feces according to 
AOAC (2006; methods 934.01 and 942.05). Total lipid content was determined by acid hydrolysis 
followed by ether extraction according to the methods of the American Association of Cereal 
Chemists (1983) and Budde (1952). Crude protein (CP) content of the diets and fecal samples 
were done by measuring total nitrogen using a LECO TruMac (model 630-300-300) and following 
the Official Method of AOAC International (2002). Diet and fecal total dietary fiber (TDF) content 
were analyzed according to Prosky et al. (1992) and the Official Method of AOAC International, 
2006 (Methods 985.29 and 991.43). Diet, fecal, and urine samples were analyzed for gross energy 
(GE) by bomb calorimeter (Model 6200, Parr Instruments Co., Moline, IL). Urine GE values were 
used to calculate ME.  
 47 
 Fecal SCFA and BCFA concentrations were analyzed using gas chromatography according 
to the methods of Erwin et al. (1961) and Goodall and Byers (1978). Gas chromatography also 
was used to measure phenols and indoles as cited in Flickinger et al. (2003). Fecal ammonia 
concentrations were determined according to the method of Chaney and Marbach (1962). 
Statistical Analysis 
 All data were analyzed using SAS (SAS Institute Inc., version® 9.4, Cary, NC), using 
MIXED Model procedures. The statistical model used diet as a fixed effect and dog as the random 
effect. Data normality was checked using the PROC UNIVARIATE procedure of SAS. 
Differences among treatments were determined using a Fisher-protected least significant 
difference test with a Tukey adjustment to control for type-1 experiment-wise error. A probability 
of P ≤ 0.05 was accepted as statistically significant and reported pooled standard errors of the 
mean (SEM) were determined according to the Mixed Models procedure of SAS.    
DNA Extraction, Amplification, Sequencing, and Bioinformatics 
Total DNA from fresh fecal samples was extracted using Mo-Bio PowerSoil kits (MO BIO 
Laboratories, Inc., Carlsbad, CA) and DNA concentration was quantified using a Qubit® 2.0 
Fluorometer (Life technologies, Grand Island, NY). Amplification of the 16S rRNA gene was 
completed using a Fluidigm Access Array (Fluidigm Corporation, South San Francisco, CA) in 
combination with Roche High Fidelity Fast Start Kit (Roche, Indianapolis, IN). The primers 515F 
(5′-GTGCCAGCMGCCGCGGTAA-3′) and 806R (5′-GGACTACHVGGGTWTCTAAT-3′) that 
target a 291 bp-fragment of V4 region were used for amplification (primers synthesized by IDT 
Corp., Coralville, IA; Caporaso et al., 2012). Fluidigm specific primer forward (CS1) and reverse 
(CS2) tags were added according to the Fluidigm protocol. Fragment Analyzer (Advanced 
Analytics, Ames, IA) was used to confirm the quality of amplicons’ regions and sizes. A DNA 
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pool was generated by combining equimolar amounts of the amplicons from each sample. The 
pooled samples were then size selected on a 2% agarose E-gel (Life Technologies, Grand Island, 
NY) and extracted using Qiagen gel purification kit (Qiagen, Valencia, CA). Cleaned size-selected 
pooled products were run on an Agilent Bioanalyzer to confirm appropriate profile and average 
size. Illumina sequencing was performed on a MiSeq using v3 reagents (Illumina Inc., San Diego, 
CA) at the W. M. Keck Center for Biotechnology at the University of Illinois. Fluidigm tags were 
removed using FASTX-Toolkit (version 0.0.14), and sequences were analyzed using QIIME 1.9.1 
(Caporaso et al., 2010). High quality (quality value ≥ 20) sequence data derived from the 
sequencing process were demultiplexed. Sequences were then clustered into operational 
taxonomic units (OTU) using opened-reference OTU picking against the Greengenes 13_8 
reference OTU database with a 97% similarity threshold. Singletons (OTUs that were observed 
fewer than 2 times) and OTUs that had less than 0.01% of the total observation were discarded. A 
total of 2,174,997 reads were obtained, with an average of 67,968 reads (range = 40,335-88,936) 
per sample. Rarefaction curves based on observed species, Chao1, and phylogenetic distance 
whole tree measures plateaued, suggesting sufficient sequencing depth (Fig. 3.1). The dataset was 
rarified to 40,335 reads for analysis of diversity and species richness. Principal coordinates 
analysis (PCoA) was performed, using both weighted and unweighted unique fraction metric 
(UniFrac) distances that measured the phylogenetic distance between sets of taxa in a phylogenetic 
tree as the fraction of the branch length of the tree, on the 97% OTU composition and abundance 
matrix (Lozupone et al., 2005). 
RESULTS  
All four diets were formulated targeting a similar nutrient profile and to be isonitrogenous 
and isocaloric (Table 3.1). Analyzed chemical composition of the experimental diets revealed that 
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while all diets were isocaloric and had similar chemical composition, ash, OM, and AHF 
concentrations were a few percentage units higher in the CT and GP diets (Table 3.2). Among the 
four experimental diets, DM content ranged from 93.11 to 94.61%. On a DM basis (DMB), OM 
was higher in the diets FP and FG (average 94.9%) compared to CT and GP diets (average 92.6%). 
In addition, analyzed chemical composition of the experimental diets revealed that CT and GP 
diets had a higher CP concentration of approximately 30.8% on DMB vs. 26.3% for FP and FG 
diets, respectively. Lastly, TDF content of diets also revealed a bimodal pattern among the four 
diets, since CT and GP diets had lower TDF (12 and 12.7%, respectively) compared to FP and FG 
(13.5 and 15.9%).  
Daily food intake (DMB), fecal output g/day (as is), fecal output g/day (DMB), and fecal 
score did not differ (P > 0.05) among treatments (Table 3.3). Likewise, ATTD of DM, OM, CP, 
AHF, digestible energy, and metabolizable energy were not affected (P > 0.05) by treatment. 
However, TDF digestibility was greater for dogs fed the FG diet in contrast with dogs fed the CT 
diet (P < 0.05) and GP diet (P < 0.05), while dogs fed FP had intermediate TDF digestibility but 
not different from either FG, GP, or CT. All four experimental diets had DM digestibilities above 
80%. Values ranged from 81.6% (CT) to 84.4% (FP). Digestibilities of CP were all above 86% in 
the four experimental diets, ranging from 86.6% (FG) to 87.2% (GP). Digestible energy was also 
higher than 86% for all diets and it varied from 87.4% (CT) to 88.1% (FG). Similarly, AHF 
digestibility was above 94% for all diets, ranging from 94.29% (GP) to 94.86% (FG) (Table 3.3).   
 Dogs fed the GP diet had a higher fecal pH (P < 0.05) compared to dogs on FG diet, 
whereas dogs fed CT and FP diets did not differ from either GP- or FG- fed dogs (Table 3.4). 
Fecal total SCFA and acetate concentrations were greater (P < 0.05) in dogs fed FP and FG diets 
compared to fecal samples of dogs fed CT and GP diets. Similarly, fecal concentrations of 
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propionate was greater (P < 0.5) in FP and FG treatments compared to GP, with CT being 
intermediate. Fecal concentration of butyrate did not differ among treatments (P > 0.05). Likewise, 
total BCFA acid concentrations did not vary among treatments (P > 0.05). However, fecal 
concentrations of isobutyrate and isovalerate were greater (P < 0.05) for dogs fed CT compared 
with dogs fed FP, GP, or FG diets. Fecal concentration of valerate tended (P = 0.063) to be greater 
for FP compared to GP, and FG and CT had intermediate values (Table 3.4). Total phenol and 
indole concentrations were the highest in CT (P < 0.05) compared to FP, FG, and GP; FP, FG and 
and GP did not differ from each other (P > 0.05). Fecal indole and ammonia concentrations were 
the greatest (P < 0.05) in CT in contrast with FP, FG and GP treatments. However, the latter three 
treatments did not differ from each other (P > 0.05). Lastly, phenol concentrations were not 
different among the four treatments (P > 0.05; Table 3.4).        
 Serum chemistry profiles of dogs fed all four diets were within the reference range for adult 
dogs and did not differ among treatments (P > 0.05; Table 3.5). Likewise, complete blood count 
results were normal among all dogs and dietary treatments (data not shown). All dogs remained 
healthy, without any signs of gastrointestinal discomfort or intolerance.   
 Alpha-diversity measures suggested that dietary supplementation of fiber and prebiotic 
blend (FP) and (or) gut health promoter additive (GP or FG) did not affect species richness; 
observed species at the 97% level OTUs and phylogenetic diversity whole tree matrix (Fig. 3.1A 
and 3.1B, respectively). Likewise, PCoA of weighted and unweighted UniFrac distances 
performed on the 97% OTU abundance matrix revealed no distinct separation (P > 0.05) on the 
beta-diversity of gut microbial communities of dogs fed the experimental diets  (Fig. 3.2A and 
3.2B, respectively). Notably, the first 3 axes of the unweighted and weighted PCoA accounted for 
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over 60% of the variation in our study.  Greengenes classifier assigned usable raw reads to 6 phyla, 
26 families, and 48 genera (Fig. 3.3A, 3.3B, and 3.3C, respectively).  
The most abundant phyla included Firmicutes (52.0% of sequences), Fusobacteria (22.9% 
of sequences), Bacteroidetes (20.5% of sequences), and Proteobateria (3.8% of sequences). 
Actinobacteria (0.9%) and Deferribacteres (0.01%) were also present. Inclusion of fiber and 
prebiotic blend and (or) gut health promoter additive did not alter the proportions of bacterial phyla 
in the canine fecal microbial community (P > 0.05).  
Also, the most abundant families included Veillonellaceae (23.0%) and Bifidobacteriaceae 
(16.2%), and the relative abundance of both did not differ among treatments (P > 0.05). Relative 
abundance of Eubacteriaceae was higher in GP compared to FP (P < 0.05). Relative abundance of 
Peptostreptococcaceae was lower in GP compared to FG (P ≤ 0.05) and FP (P ≤ 0.05), and CT had 
an intermediate value.  
Finally, the most abundant genera were Fusobacterium (22.9%), Bacteroides (16.2%), and 
Clostridium (13.2%). There was no significant difference in these genera among the four dietary 
treatments. However, relative abundance of Prevotella was higher in CT compared to FP (P < 
0.05). Peptococcus was higher in GP compared to FP (P < 0.05). Megamonas was higher in FG 
(P < 0.05) and in FP (P < 0.05) compared to GP. Parabacteroides was higher in FP compared to 
FG (P < 0.05). Finally, Peptostreptococcaceae was higher in FG compared to GP (P < 0.05). 
Overall, relative abundance of fecal microbial communities was minimally impacted by dietary 
fiber source, prebiotic, and/or gut health promoter supplementation, despite significant 
physiological alterations in fecal metabolites. Relative abundance of bacterial phyla, families, and 
genera impacted by dietary treatment of dogs fed diets containing selected fiber sources, prebiotics 
and gut health promoter are illustrated in Table 3.6.  
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DISCUSSION 
Diet, Food Intake, and Fecal Characteristics 
All four experimental diets were formulated targeting similar nutrient and ingredient 
composition, except for the source of dietary fiber (i.e., cellulose and beet pulp), prebiotic (i.e., 
inulin, MOS and FOS) and gut health promoter additive. Both FP and FG diets had the same 
sources of dietary fiber (i.e., beet pulp and cellulose) and prebiotics (i.e., inulin, FOS, and MOS); 
the only difference in the ingredient composition between the two diets was the addition of the gut 
health promoter in the FG treatment. Likewise, both CT and GP diets had the same sources of 
dietary fiber (i.e., cellulose) without inclusion of prebiotics in their formulation; the only difference 
in the ingredient composition between these two diets was the addition of the gut health promoter 
additive in the GP treatment. The fact that the ingredient composition of CT and GP was more 
similar than between FP and FG could likely explain the bimodal pattern that was observed in the 
macronutrient composition of the four experimental diets, since FP and FG were more similar to 
each other in contrast with CT and GP diets.  
Beet pulp and cellulose are traditional dietary fiber sources used in complete and balanced 
diets of companion animals. They differ in their chemical composition and physiochemical 
properties, which impact fiber fermentability and physiological outcomes (de Godoy et al., 2013). 
Plant by-products vary in chemical composition due to several factors - plant species and variety, 
maturity at harvest, environment, harvest date, plant anatomy, plant morphology, and others 
(Fahey et al., 2002). Thus, the variation in TDF concentration among the four diets is expected, 
especially for the FP and FG that contained beet pulp as the main dietary fiber source, which is an 
known ingredient to have a wide variation in TDF content (Fahey et al., 1990a; Sunvold et al., 
1995a,c).  
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In the present study, the comparable chemical composition and caloric density of the four 
experimental diets resulted in similar food intakes among dogs fed these diets. Fahey et al. (1990a) 
reported that dogs consuming diets with increasing concentrations of beet pulp (from 2.5 to 12.5%) 
had a linear increase (P < 0.05) in daily DM intake by 4.5%. Moreover, the same group of 
researchers reported a significant (P < 0.05) decrease in DM, OM, nitrogen, and TDF intake when 
dogs consumed a diet without dietary fiber supplementation, due to its higher caloric density 
(Fahey et al., 1992). In addition, Swanson et al. (2002a,b) also did not find differences in daily 
food intake by supplementing FOS in extruded diets of adult dogs. More recently, Bosch et al. 
(2009) researched the effects of dietary fiber type on satiety-related hormones and voluntary food 
intake by dogs. They authors reported that dogs fed a high fermentable fiber diet (i.e., 8.5% beet 
pulp + 2% inulin; TDF 12.4% on DMB) tended to ingest less food than dogs fed a low fermentable 
fiber diet (i.e., 8.5% cellulose; TDF 9.4% on DMB). This response might have been due to the 
increased SCFA production by the high fermentable fiber group, which could serve as an energy 
source and induce satiety in those animals. In the present study, even with the higher production 
of SCFA observed in dogs fed the FP and FG diets, food intake did not vary.  
Supplementation of fiber and prebiotic blend and (or) gut health promotor did not affect 
fecal scores, and these were all within the acceptable range of 2.5 to 2.9 on a 5-point scale.  Kroger 
et al. (2017) reported no significant differences in fecal scores of dogs fed three different diets 
containing either 12% sugar beet pulp (TDF 13.1% DM), 2.7% sugar beet pulp (TDF 5.71% DM), 
and 2.7% lignocellulose (TDF 6.72% DM), and those were also reported to be within acceptable 
ranges, (2.12 – 2.29), using the same 5-point scale. Fahey et al. (1990a) reported a linear increase 
in the quantity of wet feces excreted (g/d) with increasing level of beet pulp in the diet (0, 2.5, 5.0, 
7.5, 10.0, and 12.5% TDF), which was due to increased water holding capacity of beet pulp. 
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Cellulose is mainly an insoluble fiber, whereas beet pulp contains both soluble and insoluble fibers, 
which could have resulted in a higher fecal score for the diets FP and FG. However, soluble and 
insoluble fiber amounts were not very different among the four diets, which might explain similar 
fecal scores presented herein. Additionally, the use of a prebiotic also was reported to not affect 
fecal score of dogs. Alexander et al. (2018) used inulin at 1.0% of the diet and reported no 
significant difference in fecal score of dogs, which remained at an ideal range (2.5 – 2.6). Also, 
Swanson et al. (2002a) reported no difference in fecal scores of dogs supplemented with 2 g of 
FOS.   
Finally, as-is and DM fecal output did not differ in dogs fed the four treatments, however 
FP and FG treatments had the lowest numerical values, likely due to the greater concentration of 
soluble fibers and TDF digestibility. Beet pulp can increase fecal output (Fahey et al., 1992), but 
in that study, the inclusion of this ingredient was three times greater (7.5% beet pulp) than in our 
study (2.17%). Supplementation of 0.5% of either oligofructose, xylooligosaccharide (XOS), or 
MOS to a corn and poultry meal-based extruded diet had no effect on fecal DM excretion by adult 
dogs (Strickling et al., 2000).  
Apparent Total Tract Macronutrient and Energy Digestibility  
 Nutrient digestibility is an important factor to be considered when adding fiber to a diet, 
since different fiber sources have been shown to affect nutrient digestibility depending on their 
quality and quantity (Fahey et al., 1990a,b; Lewis et al., 1994; Silvio et al., 2000). Soluble fibers 
are generally more fermentable and better energy substrates for gastrointestinal microorganisms 
and the host than is insoluble fibers. In 1996, Zentek fed Beagles three diets with different sources 
of dietary fiber: cellulose (insoluble fiber source), pectin (soluble fiber source), and guar gum 
(soluble fiber source) at 10% inclusion rate of the diet. He reported a lower apparent digestibility 
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of DM for the cellulose diet (80.3±1.3%) compared to pectin (89.6±1.7%) and guar gum 
(88.1±1.3%). Besides, acid detergent fiber digestibility also was lower for the cellulose-containing 
diet (20.2±11.8%) compared to guar gum (47.1±6.3%) and pectin (75.0±5.9%) diets. However, in 
the experiment, the difference between soluble and insoluble fiber among treatments was greater 
(approximately 70% soluble fiber for pectin and guar gum diets and 5% for the cellulose diet) than 
in the present study, which could explain why digestibility of DM, OM, CP, and AHF from CT 
and GP did not differ from FP and FG.  
Fahey et al. (1990a) fed 30 female English Pointers an isonitrogenous diets containing 0, 
2.5, 5.0, 7.5, 10.0, or 12.5% beet pulp. They concluded that increasing beet pulp concentrations in 
the diet decreased linearly ATTD of DM, OM, and AHF. In that same study, an inclusion level of 
2.5% beet pulp (TDF 9.2%  DMB) resulted in slightly greater apparent digestibility of DM, OM, 
AHF, and CP (89.4, 92.2, 95.5 and 91.6%, respectively), than the  FP and FG treatments of the 
present study, which had an inclusion level of beet pulp of  2.17%. However, the TDF content of 
FP and FG diets were 13.5 and 15.9% on DMB.  Contrasting our findings with the highest inclusion 
level of beet pulp (12.5%; TDF of 13.7% DMB) that was used by Fahey et al. (1990a), digestibility 
of DM, OM, AHF, and CP were 84.3, 87.6, 93.7, and 88.5%, respectively, similar to the values 
obtained in this present study. Similarly, dogs fed diets containing either 12% of beet pulp (TDF 
13.1% of DM), 2.7% of beet pulp (TDF 5.71% of DM), and 2.7% of lignocellulose (TDF 6.72% 
of DM) had significantly lower apparent digestibility of OM and CP of 86.7 and 82.5%, 
respectively, when fed 12.5% beet pulp compared with 90.9 and 87.9% for the 2.5% beet pulp diet 
(Kroger et al., 2017). Thus, these results indicate that not only dietary fiber type, but also the total 
dietary fiber content must be considered when formulating pet foods, as both factors can influence 
physiological outcomes.  
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The effects of dietary fibers with various fermentation characteristics on nutrient digestion 
were previously tested by Muir et al (1996). In that study, five diets were formulated using different 
inclusions of cellulose (insoluble fiber), pectin (soluble fiber) and beet pulp: 1) 0% supplemental 
fiber (control); 2) 7.5% cellulose; 3) 7.5% beet pulp; 4) 5% cellulose and 2.5% pectin (high 
cellulose mixture); 5) 2.5% cellulose and 5% pectin (low cellulose mixture). Concentration of TDF 
ranged from 2.6% DMB (control diet) to 9.7% (both low and high cellulose mixtures). Increasing 
dietary cellulose concentrations decreased (P < 0.05) DM (77.1%), OM (82.2%), and CP (86.7%) 
digestibilities compared with the control diet. In the present study, CT and GP diets were also 
formulated with 5% cellulose, but resulted in slightly greater DM (avg. 81.9%), OM (avg. 86.5%) 
and CP (avg. 87.3%) digestibilities as those reported by Muir et al. (1996) who reported that ATTD 
of CP tended (P < 0.1) to be lower in diets containing 7.5% beet pulp (86.3%) and 5% pectin 
(86.7%). Fermentable dietary fibers lead to microbial growth and greater proportions of microbial 
N excretion in feces. Sunvold et al. (1995a) also reported lower ATTD of CP as a result of greater 
microbial N excreted in feces when dogs were fed a diet containing soluble fibers, such as beet 
pulp, citrus pulp, citrus pectin, and guar gum. Besides, dietary fiber also may have an abrasive 
effect on the gastrointestinal mucosa, which increases the elimination of endogenous proteins such 
as sloughed cells and result in a lower ATTD of CP (Wilfart et al., 2007). In the present study, 
ATTD of CP was similar among treatments (range 86.55 to 87.33%).   
While insoluble and poorly fermentable fibers may reduce transit time and total tract 
nutrient digestibility, highly fermentable oligosaccharides appear to have a smaller impact. 
Strickling et al. (2000) fed adult mixed breed female dogs four different corn and poultry meal-
based extruded diets (30% CP and 15% AHF) supplemented with 0.5% of each oligosaccharide 
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product at the expense of cornstarch as follows: control (no supplementation), FOS, MOS, and 
XOS. No significant effects of dietary oligosaccharides on ileal or ATTD of DM and CP occured. 
Swanson et al. (2002b) also fed ileal cannulated dogs extruded diets containing high 
concentrations of protein (36.8%) and fat (20.9%), and twice daily at each feeding, they received 
a gelatin capsules with either one of the following: control capsules (no supplemental FOS or 
MOS), 1 g of FOS, 1 g of MOS, or 1 g of FOS + 1 g of MOS. Authors reported that neither FOS 
nor MOS affected ileal or total tract macronutrient digestibility of DM or CP. In contrast, Zentek 
et al. (2002) reported lower (P < 0.05) digestibility of DM, CP, and N-free extract by dogs 
supplemented with MOS (1 g/kg BW/d) compared with other dietary treatments (i.e., 
transgalactooligosaccharides, lactose, or lactulose).  
The greater TDF digestibility by dogs fed the FG diet is not surprising, since this treatment 
contained the highest concentration of soluble dietary fiber. However, this finding also suggests a 
synergistic effect between the fiber and prebiotic blend with the gut promoter, enhancing microbial 
activity and improving fiber degradation by gut microbiota. As expected, dogs fed the CT and GP 
diets had the lowest TDF digestibility due to the greater ratio of insoluble to soluble fiber (8.9:3.2 
and 9.0:3.7, respectively). Insoluble fibers are less fermentable in the large intestine of monogastric 
animals and they can accelerate digesta passage and relieve constipation (i.e., laxative effect). 
Higher TDF digestibility was also observed by Fahey et al. (1992) when dogs were fed 7.5% beet 
pulp (61.1%). Sunvold et al. (1995a) performed two experiments to evaluate single source and 
blends of dietary fibers in dog foods; they reported a wide range of TDF digestibilities depending 
on fiber source. In that experiment, dogs consuming the 7.5% cellulose diet and the 5.6% cellulose 
+ 1.9% gum arabic diets, had the lowest (P < 0.05) TDF digestibility (11.0 and 4.1%, respectively) 
compared to dogs fed diets containing soluble fibers, (7.5% beet pulp [TDF digestibility 29%] and 
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7.5% citrus pulp [TDF digestibility 43%]). Middelbos et al. (2007) also reported similar findings. 
Six adult dogs were assigned to one of the following diets: 1) control diet – no supplemental 
fermentable carbohydrate (1.5% TDF); 2) 2.5% cellulose 3) 2.5% beet pulp; 4) 1.0% cellulose + 
1.5% short-chain FOS; 5) 1.0% cellulose + 1.2% short-chain FOS + 0.3% yeast cell wall; 6) 1.0% 
cellulose + 0.9% short-chain FOS + 0.6% yeast cell wall. Total tract DM, OM, and TDF 
digestibilities were lowest for the cellulose treatment. In the present study, the highest TDF 
digestibility was observed in dogs fed ET, indicating not only a higher fermentation of the fiber 
and prebiotic blend, but also a possible synergistic effect with the gut health promoter additive.     
Dietary fibers can affect satiety, but are also effective in diluting the caloric density and, 
consequently, decreasing digestible energy (DE) and ME of diets (Weber et al., 2007; Wenk 2001).  
Fahey et al. (1990a) reported similar ME intake (kcal/d) of dogs fed isonitrogenous diets 
containing increasing levels of  beet pulp (0, 2.5, 5.0, 7.5, 10.0, or 12.5%); however, when ME 
was expressed in kcal/g  DM consumed, a linear decrease was noted with increasing level of 
dietary fiber. The DE reported for dogs fed 12.5% beet pulp (13.7% TDF) was 89%, which is 
similar to the DE observed in the present study, which ranged from 87.4 to 88.1%.   
  Overall, the similar ATTD of DM, OM, CP, AHF, DE, and ME among treatments is most 
likely due to the similar ingredient and chemical composition of these experimental diets, except 
for the dietary fiber composition.   
Fecal Fermentative End-Products and Serum Chemistry 
 Fecal fermentative end-products were affected by treatments. When dietary fiber enters the 
large intestine, microbial enzymes act on this substrate, resulting in the production of SCFA, which 
are the major end-products of microbial activity and saccharolytic fermentation. The chemical and 
physical characteristics of dietary fibers may modify the intestinal microbiota or its metabolic 
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activity by influencing the fermentation pattern of SCFA (Sunvold et al., 1995a; Zentek, 1996). In 
the present study, fecal acetate, propionate, and butyrate concentrations represented 64.8%, 25.9% 
and 9.3% of total SCFA, respectively. Swanson et al. (2002b) reported similar concentrations for 
dogs supplemented with 1 g of FOS and 1 g of MOS, with acetate, propionate, and butyrate 
representing 63, 26 and 11% of the SCFA, respectively. Sunvold et al. (1995a) measured SCFA 
production using an in vitro technique and reported that dogs supplemented with mainly poorly 
fermentable fibers such as cellulose had a higher acetate:propionate ratio (3.8:1) compared to dogs 
supplemented with fermentable fiber such as citrus pulp (2.2:1). Similarly, in the present study, 
acetate:propionate was highest for diets FG (2.5:1) and FP (2.6:1) compared to CT (2.0:1) and GP 
(2.4:1).  
Moreover, in support of our findings, previous literature showed that supplementation of 
fermentable fibers might increase fecal concentrations of SCFA. Silvio et al. (2000) compared the 
use of cellulose (slowly fermented fiber) and pectin (soluble, rapidly fermented fiber) in dogs and 
reported that ileal concentrations of acetate increased and propionate decreased as pectin increased 
in the diet. Also,  Bosch et al. (2009) fed dogs either a low-fermentable fiber diet containing 8.5% 
cellulose (9.4% TDF on DMB) or a high-fermentable fiber diet containing 8.5% sugar beet pulp 
and 2% inulin (12.4% TDF on DMB). The dogs fed the high-fermentable fiber diet had a total 
SCFA concentration of 540 µmol/g, whereas dogs fed the low-fermentable fiber diet a total of 260 
µmol/g. In the present study, fecal total SCFA concentrations of dogs that consumed FP and FG 
diets were about 500 µmol/g. In addition, Alexander et al. (2018) also supplemented dogs with 
inulin at 0.5% or 1% of diet. The authors reported a total SCFA of 408.9 µmol/g for the high dose 
group (1% inulin), which was greater (P < 0.05) than for the other groups. The fecal concentrations 
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of acetate, butyrate, and propionate were also greatest for this group, suggesting that a high dose 
of inulin-type prebiotic may modulate fecal metabolites.  
Production of SCFA by microbial fermentation in the hindgut also lowers luminal pH and 
creates an environment less favorable for pathogenic species to flourish (Swanson et al., 2002b). 
In the present study, dogs that were fed diets containing fiber and prebiotic blend (FP and FG) had 
greater total fecal SCFA concentration and lower fecal pH. Short-chain fatty acids, especially 
butyrate, are the main energy source for colonocytes (Roediger, 1982). Thus, increased production, 
absorption, and metabolism of SCFA in the hindgut of dogs fed the fiber and prebiotic blend may 
support gut and host health. However, determination of fecal SCFA concentration is not an 
accurate representation of the total SCFA production in the hindgut, but it has been used and 
accepted as a proxy measurement in non-invasive animal studies. In addition, prebiotics are rapidly 
fermented by colonic bacteria, which may affect the microbial populations and metabolites in the 
proximal colon without many effects on microbial populations and/or metabolites in lower regions 
of the large bowel or in feces (Swanson et al., 2002c).   
Ammonia, phenols and indoles, and BCFA are putrefactive components that are derived 
from protein fermentation (Miner and Hazen, 1969). These compounds cause foul-smelling feces, 
which can be an unappealing quality to a diet from the pet owner’s point of view (O’Neill and 
Phillips, 1992). Silvio et al. (2000) reported higher concentrations of ammonia in dogs when 
cellulose was used as the main dietary fiber source compared to dogs fed a pectin-rich diet. The 
same authors reported a linear decrease in ileal isobutyrate and isovalerate concentrations with 
increasing levels of pectin (soluble fiber) in the diet. Increased fecal ammonia concentration in 
dogs fed diets containing primarily cellulose may indicate higher protein fermentation. In the 
present study, the hypothesis of higher protein fermentation matches with the findings related to 
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fecal BCFA concentrations, which were greater in dogs fed the CT diet. Fecal concentrations of 
isobutyrate and isovalerate were higher in dogs fed the CT diet, and they result from protein 
fermentation. Amino acids and protein that are not digested in the small intestine will be subjected 
to proteolytic action by gut bacteria, resulting in the production of putrefactive compounds (Barry 
et al., 2010). Another interesting finding is that dogs receiving the diet containing cellulose alone 
as a source of fiber, but with the addition of the gut health promoter (GP), had similar 
concentrations of fecal ammonia and branched chain fatty acids as dogs fed the diets containing 
fiber and prebiotic blend (FP and FG). This finding suggests a beneficial effect of the gut health 
promoter on substrate utilization by gut microbes that warrants further evaluation.   
As was mentioned previously, undigested proteins in the small intestine are subjected to 
microbial fermentation in the large intestine, resulting in the formation of putrefactive compounds 
in the hindgut like phenols, indoles, ammonia, and BCFA. Given the high variability in phenol 
concentration among samples (SEM = 0.24), no significant differences were observed among 
treatments. However, dogs fed the CT diet had numerically higher values than dogs fed the other 
three diets, especially compared to dogs fed FP and FG diets that contained the fiber and prebiotic 
blend. Total indole and phenol concentration was significantly different in dogs fed the CT diet 
vs. FP, FG and GP diets, which indicates a beneficial effect of the fiber and prebiotic blend and 
gut health promoter in decreasing the production of putrefactive compounds. Similarly, dogs fed 
the CT diet had greater fecal indole concentrations than dogs fed the other three diets. These 
findings suggest a possible benefit of dietary supplementation of the gut health promoter, since 
dogs fed the GP diet responded similarly to dogs fed the diets containing the fiber and prebiotic 
blend (FP and FG). A potential mechanism that could explain the lower levels of BCFA and 
phenols and indoles in the GP group is due to its antimicrobial activity. Swanson et al. (2002c) 
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reported that 2 g of FOS supplementation decreased fecal ammonia, isobutyrate, isovalerate, and 
total branched-chain fatty acid concentrations. In another study, Swanson et al. (2002a) 
demonstrated that dogs supplemented with 1 g of FOS and 1 g of FOS + 1 g of MOS had lower 
fecal total indole and phenol concentrations. In the present study, dogs received a lower dose of 
FOS, MOS, and inulin; considered their average food intake, they consumed around 0.37 g of 
FOS, MOS, and inulin, totalizing 1.11 g/day.  
Finally, serum chemistry and complete blood count results indicate that neither the addition 
of fiber and prebiotic blend nor the supplementation of a gut health promoter had any negative 
health implications for the dogs, with all blood metabolites evaluated being within reference ranges 
for healthy dogs.  
Fecal microbial composition  
The gastrointestinal microbiota contains a complex population of microorganisms, and 
their role in health and disease is of importance. Non-digestible fibers such as fructo-
oligosaccharides are fed to dogs to modulate microbial communities, increasing the abundance of 
beneficial taxa (e.g., lactobacillus and bifidobacterium; Garcia-Mazcorro et al., 2017; Redfern et 
al., 2017). In the present study, however, the inclusion of the fiber and prebiotic blend and (or) the 
gut health promoter additive did not affect species richness and diversity. Similar to the findings 
reported by Suchodolski et al. (2008), the most abundant phyla found in the dog fecal microbiota 
were Firmicutes, Fusobacteria, and Bacteroidetes, which characterize the colon/fecal sample of 
healthy dogs. Thus, in the present study, supplementation of the blend of prebiotics and fibers 
and/or the gut health promoter did not affect the proportions of bacterial phyla expected in a 
healthy canine fecal sample. 
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Although we hypothesized that supplementation with the fiber blend and prebiotic and the 
gut health promoter would beneficially shift the fecal microbiota and increase the abundance of 
beneficial bacteria such as Bifidobacterium spp. and Lactobacillus spp., this was not observed in 
the present study. Similarly, Alexander et al. (2018) reported that supplementation of inulin-type 
prebiotic at 1% of the diet did not result in an increased relative abundance of either 
Bifidobacterium or Lactobacillus spp. In the present study, although phyla were not altered, there 
was a decrease in the Eubacteriaceae family for dogs fed FP compared to GP. Omori et al. (2017) 
reported that Eubacteriaceae was increased in dogs that had inflammatory bowel disease and 
intestinal lymphoma. In the present study, the family Peptostreptococcaceae was lower in dogs fed 
with GP. Harris et al. (2015) noted Peptostreptococcaceae as one of the most abundant family in 
gingivitis and mild periodontitis in cats and dogs. Diets containing the gut health promoter (GP) 
might have a protective effect on the gut mucosa. However, this variable was not evaluated in the 
current study and warrants further evaluation.  
Additionally, the relative abundance of Megamonas was greater in dogs fed FP and FG 
diets. Megamonas is a predominant member of the family, Veillonellaceae. Members of 
Megamonas are known to produce acetic and propionic acids with fermentable fibers as the 
substrate (Kieler et al., 2017). Moreover, Beloshapka et al. (2013) fed six healthy female adult 
beagles a raw meat-based (i.e., beef or chicken) diet with or without inulin (1.4%) or yeast cell 
wall extract (YCW, 1.4%), and reported that dogs consuming diets containing inulin had the 
highest sequence percentage of Megamonas. Similarly, a study by Hidaka et al. (2008) stated that 
FOS is utilized by Megamonas. Likewise, Garcia-Mazcorro et al. (2017) reported dogs fed FOS 
and inulin at approximately 0.1% of DM intake showed a greater abundance of Megamonas. In 
that study, they also did not report a significant change in the abundance of most bacterial groups 
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in feces of healthy dogs, except for this bacterial genus. In the present study, the higher amounts 
of fermentable fiber and prebiotic in the diets FP and FG might explain the increased abundance 
of Megamonas. This greater abundance of Megamonas was associated with increased fecal 
concentrations of acetate and propionate in dogs fed the two diets. Based on these results, further 
studies might evaluate the effects of the Veillonellaceae family and/or the Megamonas genus on 
gastrointestinal health.  
Studies about the significance of Prevotella and Parabacteroides in the canine gut health 
are scarce. However, the genus Prevotella has been related to fermentation of non-starch 
polysaccharides and production of SCFA in ileal microbial communities of growing pigs (Ivarsson 
et al., 2014). In humans, this genus has been reported to synthesize enzymes involved in non-starch 
polysaccharide degradation (e.g., glucanase, mannase, and xylanase; Flint and Bayer, 2008). More 
recently, increased relative abundance of over 44% in Prevotella was observed in fecal samples of 
healthy piglets as they transitioned from nursing to weaning diets (Guevarra et al., 2018). Those 
authors suggested the increased abundance of this genus as a possible adaptive strategy to new 
dietary conditions after weaning when the piglets are being fed diets with greater concentrations 
of polysaccharide-containing ingredients. A study in rats examining the effect of resistant starch 
on the gut microbiome and its protective effect against colitis-associated colorectal cancer reported 
an increased relative abundance of Parabacteroides in rats fed resistant starch. In that same study, 
resistant starch-fed rats had decreased expression of genes related to inflammation in the colon 
(Hu et al., 2016).  Future studies are needed to explore additional benefits of the fiber blends and 
prebiotics and (or) gut health promoters on canine gut health, and a potential strategy would be 
integration of  analytical  tools such as microbiomics and metabolomics to determine possible 
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associations between dietary interventions with modulation of specific microbial taxa and 
postbiotics at local and systemic levels.  
IMPLICATIONS 
Based on the results of this study, dogs fed fiber and prebiotic blend and gut health 
promoter had no negative effects on nutrient digestibility or fecal quality, and had higher TDF 
digestibilities. In addition, dietary supplementation resulted in beneficial shifts in fecal 
fermentative end-products that may support gut health, since there was an increase in fecal SCFA 
concentrations and a decrease in phenols and indoles, BCFA, and ammonia concentrations. 
Although the test substances resulted in a modest change in fecal microbial communities of healthy 
adult dogs, it had a significant physiological effect on fecal metabolites, indicating a potentially 
better microbial profile in dogs fed diets containing these ingredients. Overall, dietary 
supplementation of test ingredients were well tolerated by dogs without any indication of 
gastrointestinal disturbance while conferring potential gut health benefits. Future studies should 
evaluate similar nutritional strategies in therapeutic diets, focusing on gastrointestinal diseases and 
obesity. 
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TABLES  
 
Table 3.1: Ingredient composition of treatments containing selected fiber sources, prebiotics and gut 
health promoter fed to adult dogs. 
 Treatments1 
Ingredient, % as-is CT FP FG GP 
Corn 36.43 36.70 36.70 36.42 
Corn gluten meal  10.00 10.00 10.00 10.00 
Rice  5.00 5.00 5.00 5.00 
Flaxseed  1.20 1.20 1.20 1.20 
Fish oil  0.50 0.50 0.50 0.50 
Poultry fat 9.00 9.00 9.00 9.00 
Poultry by-product meal 24.95 24.68 24.71 24.98 
Fish meal 2.00 2.00 2.00 2.00 
Sodium chloride 0.40 0.40 0.40 0.40 
Fiber and prebiotic blend 0.00 2.83 2.83 0.00 
Brewer`s yeast 0.50 0.50 0.50 0.50 
Cellulose powder 5.00 2.18 2.18 5.00 
Sodium hexametaphosphate 0.30 0.30 0.30 0.30 
Yucca extract 0.10 0.10 0.10 0.10 
Potassium chloride 0.60 0.60 0.60 0.60 
Palatant – liquid  2.00 2.00 2.00 2.00 
Vitamins mix 0.46 0.46 0.46 0.46 
Minerals and trace elements mix 0.41 0.41 0.41 0.41 
Palatant – powder  1.15 1.15 0.00 0.00 
Palatant + gut health promoter - powder 0.00 0.00 1.13 1.13 
1 CT = Control; FP = fiber and prebiotic blend; GP = gut health promoter additive; FG = fiber and 
prebiotic blend + gut health promoter additive. 
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Table 3.2: Chemical composition of treatments containing selected fiber sources, prebiotics and 
gut health promoter for adult canines. 
 Treatments1 
Item CT FP FG GP 
Dry matter, % 93.1 93.1 93.9 94.6 
 ----- % DM basis ----- 
Organic matter 92.6 94.9 94.9 92.5 
Ash 7.3 5.1 5.1 7.5 
Acid hydrolyzed fat 18.5 17.8 17.6 19.0 
Crude protein 30.8 26.2 26.3 30.7 
Total dietary fiber 12.0 13.5 15.9 12.8 
Soluble dietary fiber 3.2 4.7 4.8 3.7 
Insoluble dietary fiber 8.9 8.8 11.0 9.0 
Gross energy, kcal/g 5.3 5.2 5.2 5.2 
1 CT = Control; FP = fiber and prebiotic blend; GP = gut health promoter additive; FG = fiber and 
prebiotic blend + gut health promoter additive. 
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Table 3.3: Food intake, fecal characteristics, and total tract apparent macronutrient digestibility 
by adult canines fed dietary treatments containing selected fiber sources, prebiotics and gut 
health promoter.  
 
 Treatments1  
Item CT FP FG GP SEM2 
Food intake, g/d (DMB) 148.1 146.4 149.9 149.5 7.03 
Fecal output, g/d (as is) 64.5 62.4 62.9 65.7 5.41 
Fecal output, g/d (DMB) 27.1 23.1 23.5 26.7 1.78 
Fecal score3 3.0 3.0 2.7 2.8 0.29 
      
Digestibility, %      
     Dry matter 81.6 84.3 84.4 82.1 0.92 
 -----% DM basis -----  
     Organic matter 86.4 87.3 87.2 86.7 0.72 
     Acid hydrolyzed fat 94.4 94.7 94.9 94.3 0.27 
     Crude protein 87.2 86.8 86.5 87.3 0.73 
     Total dietary fiber 25.6b 36.3ab 47.0a 28.3b 3.29 
     Digestible Energy 87.4 88.1 88.1 87.7 0.65 
Digestible energy, kcal/g 4.6 4.6 4.6 4.6 0.03 
Metabolizable energy, kcal/g 4.3 4.4 4.3 4.3 0.04 
1 CT = Control; FP = fiber and prebiotic blend; GP = gut health promoter additive; FG = fiber 
and prebiotic blend + gut health promoter additive. 
2 Standard error of the mean.   
3 Fecal scores: 1= hard, dry pellets; small hard mass; 2 = hard formed, remains firm and soft; 3 
= soft, formed and moist stool, retains shape; 4 = soft, unformed stool; assumes shape of 
container; 5 = watery, liquid that can be poured. 
a-b Superscripts with different letters in a row represent statistical differences (P < 0.05). 
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Table 3.4: Fecal pH and fermentative-end product concentrations of adult canines fed diets 
containing selected fiber sources, prebiotics and gut health promoter. 
 Treatments1  
Item, µmole/g DM CT FP FG GP SEM2 
Fecal pH 6.0ab 5.8ab 5.8b 6.1a 0.09 
Total short-chain fatty acids 341.6b 497.0a 487.5a 311.0b 33.49 
Acetate 205.5b 327.0a 332.9a 195.9b 19.99 
Propionate  100.8ab 126.3a 130.5a 81.1b 9.56 
Butyrate 35.3 36.8 39.2 34.1 4.27 
Total branched-chain fatty acids 18.1 14.5 14.5 14.4 1.56 
Isobutyrate 7.6a 5.5b 5.3b 5.6b 0.51 
Isovalerate 11.2a 8.3b 8.0b 8.2b 0.80 
Valerate 0.6xy 0.7x 0.7xy 0.5y 0.09 
Ammonia 131.2a 98.1b 108.3b 105.3b 8.03 
Phenols and Indoles      
Total Phenols/Indoles 3.6a 1.9b 1.9b 2.1b 0.36 
Phenol 1.2 0.6 0.4 0.8 0.34 
Indole 2.4a 1.5b 1.5b 1.5b 0.19 
1 CT = Control; FP = fiber and prebiotic blend; GP = gut health promoter additive; FG = fiber 
and prebiotic blend + gut health promoter additive. 
2 Standard error of the mean. 
a-b Superscripts with different letters in a row represent statistical differences (P < 0.05). 
x-y Superscripts with different letters in a row represent trending differences (0.06 < P < 0.10). 
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Table Table 3.5: Fasted serum chemistry profiles for adult canines fed diets containing selected fiber sources, 
prebiotics and gut health promoter. 
  Treatments1  
Item  Reference range CT FP FG GP SEM
2 
Creatinine, mg/dL 0.5 - 1.5 0.6 0.5 0.5 0.5 0.05 
Blood urea nitrogen, mg/dL 6 - 30 12.5 10.6 10.5 11.7 1.03 
Total protein, g/dL 5.1 - 7.0 6.0 6.1 6.0 6.0 0.13 
Albumin, g/dL 2.5 - 3.8 3.3 3.4 3.3 3.3 0.08 
Globulin, g/dL 2.7 - 4.4 2.8 2.7 2.7 2.7 0.09 
Calcium, mg/dL 7.6 - 11.4 10.1 10.1 10.1 10.1 0.10 
Phosphorus, mg/dL 2.7 - 5.2 3.9 4.0 3.9 3.9 0.18 
Sodium, mmol/L 141 - 152 144.6 145.1 144.7 144.6 0.53 
Potassium, mmol/L 3.9 - 5.5 4.5 4.5 4.3 4.3 0.10 
Sodium/potassium ratio 28 - 36 32.6 32.6 33.6 33.9 0.77 
Chloride, mmol/L 107 - 118 109.5 110.0 110.2 110.2 0.76 
Glucose, mg/dL 68 - 126 90.2 90.4 92.2 90.2 2.13 
Alkaline phosphatase total, U/L 7 - 92 38.9 45.5 47.0 40.5 7.10 
Corticosteroid-induced alkaline 
phosphatase, U/L 
0 - 40 11.1 14.1 15.0 12.4 4.83 
Alanine aminotransferase, U/L 8 - 65 22.4 23.0 22.6 25.7 2.34 
Gamma-glutamyl transferase, U/L 0 - 7 3.4 3.9 3.5 3.1 0.30 
Total bilirubin, mg/dL 0.1 - 0.3 0.2 0.2 0.2 0.2 0.02 
Creatine kinase, U/L  26 - 310 96.2 112.1 90.7 102.6 15.36 
Cholesterol total, mg/dL 129 - 297 229.6 231.1 240.5 224.0 17.78 
Triglycerides, mg/dL 35 - 154 70.9 82.9 71.9 60.7 9.21 
Bicarbonate (TCO2), mmol/L 16 - 24 20.9 19.7 20.4 20.9 0.44 
Anion gap 8 - 25 18.7 19.9 18.6 18.0 0.81 
1 CT = Control; FP = fiber and prebiotic blend; GP = gut health promoter additive; FG = fiber and prebiotic 
blend + gut health promoter additive. 
2 Standard error of the mean. 
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Table 3.6: Relative abundance of bacterial phyla, families and genera impacted by dietary treatments 
of dogs fed diets containing selected fiber sources, prebiotics and gut health promoter. 
  Treatments1  
Phylum and Family  Genus 
 
CT 
 
FP 
 
FG 
 
GP SEM2 
 
Firmicutes       
Eubacteriaceae  0.2ab 0.1b 0.2ab 0.4a 0.11 
Peptostreptococcaceae  2.4ab 2.9a 2.9a 2.1b 0.27 
Veillonellaceae Megamonas 1.9ab 2.7a 2.7a 1.8b 0.31 
Bacteroidetes       
Prevotellaceae Prevotella 1.7a 1.1b 1.4ab 1.6ab 0.24 
Porphyromonadaceae Parabacteroides 0.8ab 0.9a 0.5b 0.6ab 0.10 
1 CT = Control; FP = fiber and prebiotic blend; GP = gut health promoter additive; FG = fiber and 
prebiotic blend + gut health promoter additive. 
2 Standard error of the mean. 
a-b Superscripts with different letters in a row represent statistical differences (P < 0.05). 
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FIGURES 
Figure. 3.1: Alpha diversity of observed OTUs (A) and phylogenetic distance whole tree (B) of fecal microbial communities of dogs 
fed diets containing selected fiber sources, prebiotics and gut health promoter. 
(A)                                                                                                          (B) 
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Figure. 3.2: Principal coordinated plots of unweighted (A) and weighted (B) UniFrac distances of fecal microbial communities of 
dogs fed diets containing selected fiber sources, prebiotics and gut health promoter. 
(A)                                                                                                                     (B) 
s  
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Figure 3.3:  Predominant fecal microbial communities at the phyla (A), family (B), and genera (C) levels of dogs fed diets containing 
selected fiber sources, prebiotics and gut health promoter. 
(A) 
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Figure 3.3 (cont.):  (B) 
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Figure 3.3 (cont.):  (C) 
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